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Multidrug-resistant bacteria strains possessing extended-spectrum β-lactamases (ESBLs) 
has become an increasing problem worldwide. Bacteria resistant to antibiotics are mostly 
enteric, they can contaminate the environment and, through ingestion, enter new hosts to 
cause infections. Therefore, emphasis was put on isolating ESBL-producing bacteria from 
treated wastewater. The overall aim of this thesis was to isolate, identify and characterise 
ESBL-producing bacteria from wastewater followed by isolation and characterisation of 
bacteriophages specific for these bacteria. Bacterial isolates were recovered after growth 
on selective media and multiplex PCR was used to amplify SHV, TEM, CTX-M and OXA 
genes. Biochemical test and whole genome sequencing were applied to identify and 
characterise the isolated strains. The cell-free supernatants were then used to isolate 
bacteriophages. A high titer lysate was then used to test the specificity of bacteriophages 
for different bacterial strains. The nature of phage genetic material was established and 
morphology of isolated phages was determined by the transmission electron microscopy 
imaging. Two cold-tolerant bacteria isolated harbouring CTX-M gene were studied by 16S 
rRNA gene sequence analysis and housekeeping gene sequences analysis which revealed 
that these isolates showed no close similarity to any known member of the 
Enterobacteriaceae but are related to the members of Rahnella, Rouxiella and Ewingella 
genera. The phenotypic characteristics of the two isolates were, however, discrete from 
these 3 genera. Furthermore, two different bacteriophages infected the two newly identified 
cold tolerant bacterial strains. These bacteriophages were found to be novel viruses, most 
likely belonging to the Siphoviridae family, based on their characteristics, morphology, and 
genome size. In conclusion, all the analysis showed that they two isolates belong to a novel 
genus in the Enterobacteriaceae family. Given the menacing impact of disease outbreaks 
caused by contaminated water resources, work presented here identifies novel bacteria 
with harmful capabilities and potentially offers new tools for environmentally safer treatment 
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1.0 Introduction 
Untreated water has a high health risk of causing waterborne diseases. Most disease-
causing pathogens are enteric in origin, that is, they are excreted in faecal matter, 
contaminate the environment, including drinking water, and through ingestion enter new 
hosts. Many members of the order Enterobacterales have been implicated as pathogens in 
humans and these include Vibrio cholerae causing cholera, Salmonella typhi causing 
typhoid, Shigella dysinterae causing dysentery, Yersinia enterocolitica causing yersiniosis, 
among others. 
Although advances have been made in water source protection and water treatment, 
sewage treatment plants receive wastewater from a variety of sources and have great 
microbial diversity, including microorganisms that are carbon degraders, nitrifiers, 
denitrifiers, as well as phosphate- and glycogen-accumulating bacteria (Cydzik-
Kwiatkowska and Zielinska, 2016). It is unsurprising that these treatment plants are also 
rich in diverse pathogens. However, it is concerning that treated water can be enriched for 
pathogens and antibiotic resistant bacteria which has become a global public health threat 
causing serious illness and even death. (Gomez et al 2010; Gouliouris et al 2019; Amos et 
al 2014). As a result of this and similar observations, waste-water treatment plants are 
regarded as hotspots for microbial pathogens and the spread of antibiotic resistances into 
the environment, although the processes governing this dissemination remain poorly 
understood (Ju et al 2019).  
One important mechanism in treating wastewater involves bacterial viruses 
(bacteriophages). While an appropriate wastewater treatment is efficient in removing most 
bacterial species, it is evident that bacteriophages survive the process. Through a 
phenomenon known as transduction bacteriophages can transfer resistance genes 
between bacteria during infection and thus establish a reservoir of antibiotic resistance 
genes (Lood et al., 2017). 
1.1 Wastewater treatment  
Wastewater treatment is the process of producing a final effluent appropriate for either 
disposal or reuse, by removing physical, chemical, and microbiological contaminants from 
any kind of wastewater coming from community, commercial or industrial waste. 
Wastewater treatment plant consist of different treatment levels of the wastewater which 
are employed depending on the main purpose of the treatment. The different treatment 
levels include (i) preliminary treatment, to remove coarse solids. (ii) primary treatment, to 
remove suspended solids and organic matter; (iii) secondary treatment, to remove 
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biodegradable organic matter in solution or suspension and suspended solids; (iv) tertiary 
treatment, to remove specific compounds, such as nutrients, pathogens, etc. 
(Tchobanoglous et al., 2014). 
Community wastewater treatment development started in the early 20th century in the 
United Kingdom in response to a 1908 report by the Commission on Sewage Disposal 
(OFWAT/DEFRA, 2006). The knowledge of waterborne diseases was limited at that time, 
therefore, the biological or secondary wastewater treatment systems, including the two most 
commonly used, namely activated sludge (AS) and trickling filter (TF), were developed with 
the purpose of removing organic matter and suspended solids, but pathogen levels are 
reduced by these processes. In practice, all wastewater effluent is reused either in 
agricultural irrigation, aquaculture, water toilet flushing or in industrial activities. In some 
cases, it is indirectly reused when treated wastewater is discharged directly into the large 
bodies of water and such are used for recreational activities like fishing and swimming. As 
reported by Angelakis and Durham (2008), wastewater reuse is potentially an economically 
attractive and sustainable option for water resource management. They reported that in 
2004 in Europe about 700 million cubic metres of treated wastewater were reused. In the 
UK, only 3 million cubic metres of treated wastewater were reused in 2005, but this number 
is expected to increase ten-fold by 2025 (Angelakis and Durham, 2008). 
Although reusing wastewater poses many economic and environmental advantages, a 
potential risk to human health related with waterborne pathogenic microorganisms in the 
wastewater is of great concern to the health sector. One of the leading worldwide causes 
of human morbidity and mortality documented by the World Health Organisation (WHO) is 
acute gastroenteritis, which is associated with ingestion of contaminated water (WHO, 
2011b). Waterborne pathogens have led to over 10 million deaths yearly, with Diarrhoeal 
disease alone being responsible for the deaths of 1.5 million people every year (WHO, 
2012). Most deaths related with diarrhoea globally are thought to be caused by unsafe 
drinking water or inadequate sanitation or hygiene: more than 99% of these deaths occur 
in low-income countries, and around 84% of those are children (WHO, 2009). Waterborne 
bacterial pathogens in wastewater remains an important public health concern due to the 
high cost of disinfecting wastewater by using physical and chemical methods in treatment 
plants. Bacteriophages, which have been used as biocontrol agents in phage therapy 
treatment of people, are in phage treatment of food, are now proposed for treatment of 
wastewater. Bacteriophages have been used as alternative treatments for drug resistant 
pathogens and some of the characteristics that make it unique include: high effectiveness 
in killing their target bacteria, high target specificity, adaptivity, natural residence in the 
environment and the fact that they are self-replicating and self-limiting (Jassim et al., 2016). 
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1.2  Enteric microorganisms present in wastewater 
A large range of microbial species are found in natural waters and wastewaters such as of 
bacteria, archaea, protozoa, helminths, fungi, rotifers, algae, and viruses. Most of these 
microorganisms are harmless to humans and are needed to maintain the ecological niche 
in aquatic environments. However, some of these microorganisms are defined as 
‘pathogens’ because the can trigger a variety of illnesses in humans. These pathogens have 
been divided into 4 major taxonomic groups: Bacteria, viruses, protozoa, and helminths 
(von Sperling, 2007; Tchobanoglous et al., 2014). These pathogens commonly found in 
wastewaters normally would have been previously egested by humans (and other animals) 
and can cause a wide range of diseases in humans. 
1.2.1 The Enterobacterales 
The order Enterobacterales is a large and diverse group of gram-negative, facultatively 
anaerobic, non-spore-forming, rod-shaped bacteria within the class Gammaproteobacteria. 
Members of this order are found predominantly in  soil, water  in association with living 
organisms including plants, insects, animals and humans (Brenner & Farmer, 2005). In 
prokaryotic taxonomy, there are 8 families in the order of Enterobacterales (Figure 1). The 
most diverse bacterial families currently recognized  are the Enterobacteriaceae family. 
Which constitutes the family with the most genera within the order Enterobacterales 
encompassing over 250 species. The number of genera and species of the 
Enterobacteriaceae has increased from 12 genera and 36 species in 1974, to 34 genera 
and 149 species with 21 subspecies in 2006 (Baylis, 2006), to 48 genera and 219 species 
with 41 subspecies in 2011 (Baylis et al, 2011). Currently there are over 60 genera 
representing some 250 species that are taxonomically diverse, ranging from the coliforms, 
important in monitoring health and safety standards in the water and food industries (Figure 
1), the insect symbionts of the genera Arsenophonus (belongs to Morganellaceae family), 
Buchnera (belongs to Erwiniaceae family), to the plant pathogens of the genera Erwinia, 
Brenneria or Pectobacterium (both belong to the Pectobacteriaceae family).   
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Figure 1. The Enterobacterales. (a) Variability in the ability to ferment lactose within genera of the Enterobacterales – redrawn from Baylis et al 2011. The 
genera encircled with a dotted line represent those species or strains that are variable between the different categories. (b) The eight families of the 
Enterobacterales (Alnajar and Gupta, 2017).
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Although the 16S rRNA molecule is a standard phylogenetic marker for most bacterial 
species, 16S rRNA sequence analysis is poorly informative within the family of 
Enterobacteriaceae because it reaches its limit at the order level. It is better used for 
kingdom/class/order. The classification of the Enterobacteriaceae within the 
Enterobacterales has undergone revision recently, based on the comparison of whole 
genomes including multilocus sequence analysis (MLSA) based on genes such as sucA, 
pyrG, rplB, rpoB among others (Adeolu et al 2016; Alnajar and Gupta, 2017). 
Comprehensive phylogenomics and comparative genomic analyses has resulted in the 
division of the Enterobacterales into seven families as described by clades: The 
Escherichia-Enterobacter clade; the Erwinia-Pantoea clade; the Pectobacterium-Dickeya 
clade: the Yersinia-Serratia clade; the Hafnia-Edwardsiella clade; the Proteus-Xenorhabdus 
clade and the Budivicia clade. These clades are recognised molecularly by the presence of 
conserved signature indels (CSIs). 
One of the most important clades relevant to this study is the Yersinia-Serratia one. This 
clade includes genera such as Yersinia, Rahnella, Ewingella, Rouxiella, Serratia, among 
others. 
Yersinia is a genus in the family Yersiniaceae. Yersinia species are gram-negative straight 
rods, oxidase-negative, catalase-positive, coccobacilli bacteria, and are facultative 
anaerobes. Yersinia pestis (the ‘plague bacillus’) was first identified by Alexandre Yersin in 
1894 and classified as Pasteurella pestis soon after. Von Logham reclassified Pasteurella 
pestis and Pasteurella rodentium into the new genus of Yersinia in 1944. The 
genus Yersinia contains 17 species, of which only 3 are known to be pathogenic to humans. 
These include Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis (Rogers et al., 2015). 
Yersinia spp. have a number of virulence factors that contribute to their ability to establish 
an infection in their mammalian host such as ability to evade and inhibit the immune and 
inflammatory responses of the host. Yersinia enterocolitica causes gastroenteritis and is 
the most significant Yersinia species related to water transmission. Yersinia 
enterocolitica mainly causes acute enteritis, but systemic infections, such 
as bacteraemia, joint pain, and rashes have occasionally resulted. The most common 
symptoms include fever, diarrhoea, and abdominal pain (Percival and Williams, 2013). 
Yersinia pestis is nonmotile. Other species are nonmotile at 37°C but motile at temperatures 
less than 30°C by means of peritrichous flagella. The optimal temperature for growth is 
27.8–30°C. They do not form spores or capsules, but Y. pestis produces a capsule-like 
envelope (Slack, 2010). 
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The genus Rahnella is also a member of the family Yersiniaceae. It originally consisted of 
only one species, Rahnella aquatilis, and two genomospecies. However, 5 additional 
species have now been identified: Rahnella victoriana, Rahnella variigena, Rahnella 
inusitata, Rahnella bruchi, Rahnella woolbedingensis (Brady et al., 2017). The name 
Rahnella was coined in honour of the German American bacteriologist Otto Rahn, and the 
species was termed aquatilis because it was isolated from water. 
Rahnella aquatilis is a rare gram-negative rod which is 2-3 microns in length, although 
usually found in fresh water. It has been isolated from blood, surgical wounds, and urine, 
among others (Oh & Tay, 1995; Tash, 2005). Rahnella aquatilis can cause a wide variety 
of abnormalities such as bacteraemia, sepsis, respiratory infection, urinary tract infection, 
and wound infection (Chang et al., 1999). No single biochemical feature 
differentiates Rahnella from the other Yersiniaceae. However, Rahnella does have a few 
distinguishing traits. Characteristically, it is motile at 22°C but nonmotile at 36°C, and it can 
grow at 4 to 10°C. It is also negative for lysine and ornithine decarboxylases and arginine 
dehydrolase (Tash, 2005).  
Ewingella is a new group in the Yersiniaceae family, consisting of only one species, 
Ewingella americana. It is a rare gram-negative rod first described from clinical specimens 
in 1983 by Grimont et al. Ewingella is phenotypically distinct from all other groups 
of Yersiniaceae. The members of this genus are lactose fermenting, oxidase negative, 
catalase positive, indole negative, facultative anaerobes, lipase- and deoxyribonuclease-
negative; Voges-Proskauer-positive; lysine-, orni- thine- and arginine-decarboxylase-
negative; they produce acid from glucose but fail to produce acid from L-arabinose, 
melibiose, raffinose, D-sorbitol or sucrose (Grimont et al., 1983). It rarely causes human 
infections and has been identified from various clinical samples including sputum, 
conjunctiva, blood, wound.  
Ewingella americana isolates have been reported to cause peritonitis, conjunctivitis, 
bacteraemia, and pneumonia. It can be treated with aminoglycosides, fluoroquinolones, and 
sulfamethoxazole/trimethoprim. These bacteria can survive in water and grow preferentially 
at 4 °C and this isolate is not known to be the normal flora of respiratory tract (Hassan et 
al., 2012; Esposito et al., 2019). However, it is not known whether Ewingella americana is 
a true pathogen or simply an opportunistic infectious agent, as most of the cases have been 
described in old patients and/or suffering from severe underlying conditions, such as 
complicated surgeries, injuries from accidents, drug abuse, and renal failure (Esposito et 
al., 2019). 
Introduction 
Page 7 of 137 
 
1.2.2 Pseudomonadales 
Pseudomonas species are gram-negative bacteria belonging to the family 
Pseudomonadaceae. They are psychrophilic catalase-positive obligate aerobic (they 
require presence of oxygen to survive) They are usually single curved or in the shape of 
straight rods within the class Gammaproteobacteria (Feiner, 2006). The 
genus Pseudomonas contains more than 140 species, most of which are saprophytic. More 
than 25 species are associated with humans. The most pseudomonads known to cause 
disease in humans are associated with opportunistic infections and include P. aeruginosa 
and P. maltophilia (Iglewski, 1996). 
P. aeruginosa is a gram negative, rod-shaped bacterium that is well adapted to live in moist 
environments. This versatile bacterium grows in water and can infect plants and animals as 
well as humans (Selezska et al., 2012). P. aeruginosa, are commonly found as part of the 
normal flora in the oral cavity and intestinal tracts and in the skin of some healthy persons 
(Iglewski, 1996). They have been described as nosocomial opportunistic infectious agent, 
as most of the described cases were in immunocompromised patients, ventilated patients 
in the intensive care unit and patients with burn wounds. P. aeruginosa can cause a wide 
variety of infections including pneumonia, urinary tract, and gastro-intestinal infections 
(Stover et al., 2000).  
Its ubiquitous growth capacity combined with a high intrinsic resistance against antibiotics 
and disinfectants and the ability to readily acquire resistance mechanisms makes P. 
aeruginosa an important pathogen for humans. As it is intrinsically resistant to various 
classes of antibiotics including some beta-lactam antibiotics, resistance to carbapenems 
and aminoglycosides can be acquired (Oliver et al., 2008; Strateva and Yordanov, 2009)  
1.3 Antibiotics, β-lactam antibiotics, and mode of resistance  
In trying to maintain an ecological niche, microorganisms have resulted in competitive 
interactions and battle for survival. This competition has been seen as the base for evolution 
of antibiotics millions of years ago (Medeiros,1997). Alexander Fleming, a Scottish 
physician-scientist was the first to be recognised for discovering Penicillin as early as 1928. 
He noticed an antibacterial effect from a mould isolate he later identified as belonging to 
Penicillium genus and during World War II penicillin G became available for treating 
infections (Fleming, 1929). 
Cell wall active agents, especially beta-lactam antibiotics, play a crucial role in the treatment 
of bacterial infections. β-lactam antibiotics (penicillins, cephalosporins, monobactams and 
carbapenems) are very important drugs due to their effective and broad mode of action on 
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different bacterial pathogens combined with their low toxicity in humans and animals 
(Abraham, 1981). The ß-lactam antibiotics have bactericidal effects that involves the 
inhibition of synthesis in the bacteria cell wall peptidoglycan layer. This process occurs 
through covalent attachment of antibiotics to penicillin-binding protein (PBP) on cell 
membrane (Figure 2). This enzyme catalyses the final stages in bacterial cell wall formation. 
(Drawz and Bonomo, 2010). 
 
Figure 2. The transpeptidase reaction. In order to form a rigid structure, the polysaccharide chains 
(glycans) are linked together by peptide crosslinks. The first step in the formation of the crosslinks 
involves attachment of a short five residue peptide to the MurNAc sugar in the polysaccharide. This 
peptide ends in two D-Alanine (D-Ala) residues. The top structure (1) is a polysaccharideMurNAc-
GlcNAc) with the first peptide already bound. Note that it ends in two D-Ala residues. The first step 
in the transpeptidase reaction involves binding of the enzyme (Enzyme-OH) to the D-Ala-D-Ala end 
of the chain. A reaction takes place in which one of the D-Alanine residues is released and the 
enzyme become attached to the end of the peptide (2). In the second step, an adjacent peptidoglycan 
(purple) (3) with a branched structure is covalently linked to the first peptidoglycan forming a crosslink 
between the two polysaccharides. Almost all bacteria have cell walls, and they have transpeptidase 
enzymes that catalyze this reaction (Lee et al. 2003). 
The carbapenems are usually regarded as the last resort treatment against Extended 
Spectrum β-lactamases (ESBLs) because they have the broadest spectrum and potency 
among the different β-lactams.  
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1.3.1 Antibiotic resistance  
Antibiotic resistance is defined as the ability of a bacterium to resist an antibiotic that would 
normally kill them or stop their growth. This ability to resist antibiotics is achieved through 
four core strategies (Figure 3): i) decreased permeability of bacterial membranes; (ii) 
antibiotic efflux; (iii) altered target sites; (iv) inactivating enzymes (Baker-Austin et al., 2006).  
 
Figure 3. Mechanisms of antimicrobial activity and of antibiotic resistance. (Wright, 2010) 
Most antibiotics are a product of nature and in the battle that microbes have to fight in this 
context, their ability to adapt to changes in the environment is a crucial aspect for survival 
and as such antibiotic resistance is a naturally occurring phenomenon in microorganisms 
(D'Costa et al., 2011). Horizontal gene transfer (HGT) and mutations have successfully 
given rise to new bacterial genotypes, which can spread in the larger population through 
adaptive evolution or random genetic drift (Thomas and Nielsen, 2005). Bacteria have a 
short generation time, large population size and a high rate of spontaneous mutations, 
which enables fast and effective adaptive evolution (Davies and Davies., 2010), as was 
demonstrated by the effectiveness of a wild-type E. coli evolving from a susceptible to a 
highly resistant strain (Baym et al., 2016).  
The development path of antibiotic resistance is complex and reliant on several factors 
including the level of resistance conferred by the resistance mechanism, the mutation rate 
of bacteria, the fitness of the resistant mutant and the strength of the selective pressure 
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(Hughes and Andersson, 2017). The strong burden exerted by centuries of misuse and 
overuse of commercial antibiotics in humans, animals and agriculture have augmented the 
development of antibiotic resistance in pathogenic bacteria (Levy, 1998). Plasmids which 
are replicons of extrachromosomal DNA in bacterial cells, play a significant part in the 
development of these microorganisms. They are found in most bacteria and because the 
vary in size and usually circular in form, they are very adaptable in spreading multiple traits 
such as drug resistance and virulence factors.  Some are spread by plasmids through HGT 
(Stokes and Gillings, 2011). HGT is the movement of genetic information between 
organisms and is crucial for the spread of antibiotic resistance (Burmeister, 2015). Through 
the mechanism of HGT, antibiotic resistance genes can be spread throughout an entire 
population of bacterial pathogens and spread to new bacterial species (Davies and Davies, 
2010). HGT occurs by three genetic mechanisms (Figure 4); Transformation (direct uptake 
of naked DNA), Conjugation (transfer of mobile genetic elements by pili structures 
assembled by two adjacently located bacteria) and Transduction (bacteriophage-mediated 
transfer of DNA between bacteria) (Thomas and Nielsen., 2005). In Enterobacteriaceae, 




Figure 4. Mechanisms of bacterial horizontal gene transfer a- Bacterial transformation; b- Bacterial 
transduction; C- Bacterial conjugation (Manage, 2018). 
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1.3.2 β-lactamases 
The most important resistance mechanism in bacteria is the production of β-lactamases 
that hydrolyses β-lactam ring by adding a water molecule to the common ß-lactam bond, 
and this inactivates the ß-lactam antibiotic (Figure 5).  
 
 
   
  
 
   
 
Figure 5. Hydrolysis of β-lactam antibiotics by β-lactamase enzymes 
The group β-lactamases consists of around 2800 unique proteins and were evolved in 
microorganisms to protect them from naturally occurring β-lactams in the environment. 
Based on the mechanism by which they hydrolyse β-lactam antibiotics, β-lactamases are 
classified biochemically into two groups: serine- β-lactamases and metallo- β-lactamases. 
Sequence analyses revealed four major molecular differentiations for key β-lactamases. 
This led to the establishment of molecular classes A, B, C and D (Table 1). Serine- β-
lactamases were subdivided as A, C or D while metallo- β-lactamases were classified as B. 
The four molecular classes were further subdivided based on functional capability related 





















1 C Cephalosporins - - AmpC enzymes 
from gram 
negative bacteria 
2a A Pencillins + - Penicillinases from 
gram positive 
bacteria 
2b A Pencillins 
Early cephalosporins 
+ - TEM-1, TEM-2, 
SHV-1 
2be A Extended spectrum 
cephalosporins 
Monobactams 
+ - TEM-3 to TEM-26, 
SHV-2 to SHV-6, 
Klebsiella oxytoca 
K1 
2br A Pencillins ± - TEM-30 to TEM-
36, TRC-1 
2c A Penicillins, 
carbenicillin 
+ - PSE-1, PSE-3, 
PSE-4 
2d A Penicillins, cloxacillin ± - OXA-1 to OXA-11, 
PSE-2 (OXA-10) 
2e A Extended spectrum 
cephalosporins 
+ - CepA 
2f A Penicillins, 
cephalosporins, 
carbapenems 
+ - KPC-2, IMI-1, 
SME-1 
3 B Most b-lactams, 
including 
carbapenems 








1.3.3 Extended-spectrum β-lactamases 
ESBLs are defined as active site serine Amber’s class A or class D ß-lactamases which can 
hydrolyse broad-spectrum penicillins, cephalosporins and aztreonam. They can be inhibited 
by clavulanic acid in vitro. They are located according to the Bush-Jacoby-Medeiros 
functional classification system in subgroups 2be and 2D or Amber class A or D structural 
classification (Table 1). Some ESBL-genes such as TEM-10, OXA-12 and SHV-28 in 
potential pathogenic bacteria like E. coli and K. pneumoniae originated through different 
point mutations that alter the amino acid configuration around the active sites in naturally 
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occurring β-lactamase genes like TEM-1, OXA-1 and SHV-1. Other ESBL-genes emerged 
in non-pathogenic bacteria, and were horizontally transferred to pathogenic bacteria, the 
most important example being the CTX-M ESBLs that are believed to originate from 
environmental bacteria belonging to the genus Kluyvera (Bush, 2018). Most discovered and 
identified ESBLs belong to these families: TEM with approximately 200 variants, SHV with 
over 140 variants and the most found according to published literature CTX-M with about 
130 variants. 
CTX-M-type ESBLs are the most commonly found ESBL gene in the clinic, the community 
and the environment and have spread into a global pandemic (Woerther et al., 2013). 
Fifteen AmpC β-lactamases are found in the molecular class C and functional group 1 
(Table 1), and they are categorised by their ability to hydrolyse most penicillins, extended-
spectrum cephalosporins and show resistance to clavulanic acid (Bush, 2018). AmpC β-
lactamases are encoded on the chromosomes of many bacteria belonging to the family 
Enterobacteriaceae. They are inducible in many bacteria and mutations in AmpC enzymes 
can lead to overexpression, which leads to resistance to broad-spectrum cephalosporins 
like cefotaxime and ceftazidime. AmpC genes have been transferred to transmissible 
plasmids and can thus appear in bacteria lacking or poorly expressing chromosomal AmpC, 
such as E. coli and K. pneumonia. Plasmid-mediated AmpC (pAmpC) enzymes are 
generally harder to detect, broader in conferring resistance and less common compared to 
plasmid-mediated ESBL enzymes, but certain pAmpC enzymes are prevalent in livestock 
and humans in some regions (Jacoby, 2009). Termed as the “rising star” of ß-lactamase, 
plasmid-mediated carbapenemases are the most common encoded carbapenems in 
bacteria although some bacteria have chromosomal-mediated carbapenemases. Several 
carbapenemases have been discovered and identified (Table 1). Osano et al., 1994 and 
Watanabe et al., 1991 in their research in the 1990s in Japan both reported the first case of 
isolated IMiPenem (IMP) carbapenemases in Serratia marcescens and P. aeruginosa 
respectively. Yigit et al., 2001 reported the first case of Klebsiella pneumoniae 
carbapenemases (KPCs) in the United States in 1996 while Lauretti et al., 1999 reported 
Verona integron-encoded metallo-β-lactamase (VIM) carbapenemases in Italy in 1999. 
1.3.4 Extended-spectrum β-lactamases in Rahnella and Ewingella 
Members of the genus Rahnella are commonly associated with plants while Ewingella is 
found with cultured mushrooms. They both are regarded as infrequent human opportunistic 
pathogens, which are easy to treat with specific antibiotic patterns. Rahnella and Ewingella 
are naturally resistant to several β-lactam antibiotics, which is mediated by an Amber class 
A and an Amber class C β–lactamase, respectively. The resistance gene of Rahnella, 
blaRAHN, is located on a non-mobile plasmid belonging to the pEA29 family, associated 
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commonly in plant bacteria. blaRAHN has been suggested to be present in prehistoric times 
before the divergence into genomospecies of Rahnella. blaRAHN has developed and varied 
into blaRAHN-1 and blaRAHN-2 found in Rahnella genomospecies 2 and Rahnella aquatilis, 
respectively (Rohzon et al., 2012). Because this gene is located on a non-mobile plasmid, 
the transfer of resistance genes from one pathogen to another has yet to be documented 
but several examples of chromosomal resistance genes that were transferred into 
pathogens have been documented, it cannot be excluded that blaRAHN also may spread to 
other bacteria in the future. On the other hand, using different primer combinations, the 
amplification and sequencing of the (partial) AmpC gene of the Ewingella americana strains 
WMR82 and WMR121 showed 72% identity to AmpC of Serratia proteamaculans and 
approximately 67% AmpC of other Serratia species. The origination of this AmpC gene has 
yet to be found, therefore, further studies are necessary to assess whether the Ewingella 
ampC gene is chromosome or plasmid born and its potential for transfer needs to be 
investigated (Rohzon et al., 2012). 
1.3.5 Virulence factors of extended-spectrum β-lactamases 
Virulence is the ability of an organism to infect a host and cause a disease. Virulence factors 
are the molecules that help bacteria colonize a host. These factors are either secretory, 
membrane associated or cytosolic in nature. The cytosolic factors assist the bacterium to 
undergo quick metabolic, physiological, and morphological shifts. The membrane 
associated virulence factors assist the bacterium in adhesion and evasion of the host cell. 
The secretory factors aid the bacterium to pass through the innate and adaptive immune 
responses launched inside the host (Sharma et al., 2017). Infections resulting from ESBL 
producers are associated with serious adverse conditions because of ineffective therapy 
and the failure in the choice of an antibiotic active against these isolates. However, the 
increased incidence of mortality associated with ESBL producers may also be associated 
with the increasing virulence of these isolates. One such is the pathogenicity of K. 
pneumoniae where the expression of its virulence factors such as microbial biofilm 
formation, Serum resistance among others have been linked to severe conditions (Gharrah 
et al., 2017). In a study by Pitout et al., 2005, several virulence factors were more prevalent 
among E. coli isolates that produced CTX-M enzymes compared to producers of TEM and 
SHV ESBLs. CTX-M producers were more commonly positive for afa/dra (Dr-binding 
adhesins), iha (putative adhesin-siderophore receptor), sat (secreted autotransporter 
toxin), and kpsM II. In contrast, non-CTX-M producers significantly more often 
exhibited ireA (iron-regulated element) and cvaC (colicin [microcin] V). Other virulence 
factors are colonization factors (CFs) that help enterotoxigenic E. coli attach to and colonize 
cells in the small intestine, allowing bacterial cells to produce heat-labile enterotoxins (LT) 
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and/or heat-stable enterotoxins (STh or STp) that target vital cellular processes (Margulieux 
et al., 2018). Rahnella possess root adhesins that mediates adherence to epithelial cells 
during bacterial invasion. Other virulence factors are lipopolysaccharide endotoxin and 
homoserine lactone-based autoinducer molecule thought to function in quorum sensing. 
Rahnella naturally expresses a chromosomally encoded extended-spectrum Amber class 
A beta-lactamase. It can be treated with ceftazidime, imipenem, and piperacillin-tazobactam 
(Tash, 2005). 
1.3.6 The rise of antibiotic resistance and importance of finding 
new treatments. 
The raising spread of drug-resistant bacteria has been of concern to the medical sector and 
society. As a result of the expensive cost of production of antibiotics, as well as a quick 
turnaround in acquisition of resistance to these antibiotics by bacteria, very limited new 
antibiotics are imminent. This is more observed as only four new classes of antibiotics have 
been approved since the seventies (Eriksson, 2015, Cooper and Shlaes, 2011). 
Nonetheless, fidaxomicin and bedaquiline are two classes of antibiotics approved over the 
last couple of years with a narrow spectrum for treatment of gram-positive Clostridium 
difficile and Mycobacterium tuberculosis respectively (Butler et al., 2013). The acquisition 
and spread of antibiotic resistance between bacterial species are a quick process (Davies, 
1994). This ease of spread has become a major health concern as resistant bacteria can 
be isolated within months after introduction in most new types of antibiotics. Multi-resistant 
bacteria have become a global pandemic and peak occurrences have been attributed in 
countries where there are large antibiotic prescription routines or over-the-counter 
distribution of antibiotics (Eriksson, 2015). Since 2004, this problem has been tackled by 
governments by making numerous recommendations and restrictions to antibiotic use. 
Some of these recommendations were reported in the O’Neill report (2016) of tackling drug-
resistant infections globally. One of such restrictions was the 2006 European Union ban 
(Regulation 1831/2003/EC) on additives for use in animal nutrition. All efforts have been 
focused on decreasing the spread of multi- drug resistant bacteria by reducing or ceasing 
the use of antibiotics for treating minor infections in society. Carbapenems, which are 
regarded as the last line of action for treatment against resistant bacteria have also seen 
emerging resistant isolates. This buttresses the importance of not only reducing the use of 
antibiotics but also looking at different treatment options for bacterial infections. This has 
led to a renewed interest in research into bacteriophage (phage) antimicrobial derived 
compounds as alternative or adjuvants forms of treatment (Eriksson, 2015). 
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In the last few years interest in phage therapy has grown as demonstrated by the number 
of papers published on the topic: 700 as of October 2017 (using “phage therapy” as a search 
term in the PubMed search engine). In Poland, the Hirszfeld Institute of Immunology and 
Experimental Therapy provides phage treatment for patients that have been through 
numerous ineffective antibiotic treatments whilst the Eliava Institute in Georgia, produces 
and commercializes phage cocktails, which are a mixture of phages targeting etiologic 
agents of specific diseases, such as intestinal disorders or skin infections (Kutter., 2010). 
Yet phage therapy won't be taken seriously until controlled clinical trials are published in 
major medical journals. A detailed description of the composition of the drug may aid the 
approval of phage cocktails by the European Medical Agency and the US Food and Drug 
Administration (FDA). As biological entities, phages are designed to mutate over time. 
Additionally, phages multiply at the site of infection, which has two-sides: it has the 
advantage of effective treatment even at low doses, but on the other side, it implies a 
complex pharmacokinetic that cannot be simply reconstructed. Controlled human clinical 
trials of phage therapy are required by the FDA, which also stresses the need of several 
phage therapy trials conducted against different infectious diseases (Brüssow, 2012). 
1.4 Phage Biology and classification 
Bacteriophages (phages) are infectious agents that replicate as obligate intracellular 
parasites in bacteria. They are viruses that rely on bacterial metabolism and replication 
machinery to produce and transfer their progeny. The genetic material of phages comprises 
of double-stranded DNA (dsDNA; the vast majority), single-stranded DNA (ssDNA), single-
stranded RNA (ssRNA), or double-stranded RNA (dsRNA; very rare) (Holmes and Jobling, 
1996). Also, the Baltimore classification system takes into account combination of their 
nucleic acid (DNA or RNA), strandedness (single-stranded or double-stranded), reading 
frame orientation, and method of replication, placing viruses into one of seven groups 
designated by Roman numerals and depending on their mode of replication and genome 
type (Baltimore, 1971). The electron microscope analyses allowed the discovery of different 
phage morphologies; phages can be tailed, polyhedral, filamentous, or pleomorphic, and 
some have lipid or lipoprotein envelopes (Ackermann, 2006). Since 1966, the International 
Committee on Taxonomy of Viruses (ICTV) have tried to taxonomically classify phages 
based on their genome and the morphology. Tailed phages constitute the majority (96%) of 
bacterial viruses. They belong to the order Caudovirales (from latin cauda, tail), which have 
double stranded DNA (dsDNA) as genetic material. The families in this order are 
Siphoviridae characterized with a noncontractile and flexible tail, Myoviridae, characterized 
by a straight contractile tail and Podoviridae, characterized by having a short tail (Figure 6) 
(Ackermann, 2005; Ackermann, 2009).  
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1.5 Phage Infection 
Phages have various possible life cycles which, along with interaction with their physical 
environment, dictate their role in bacterial/archaeal biology (Clokie et al., 2011). Viruses 
show two life cycles (Figure 7): lytic or lysogenic cycles. In the lytic cycle, the (lytic or 
virulent) phage lyse the bacterial cell upon infection, introducing their genetic material into 
the host and redirecting the host metabolisms towards the production of new phage, which 
are released during the lysis of the cell. In the lysogenic cycle, the genome of the (temperate 
or lysogenic) phage characteristically remains in the host in a prophage stage (inactive) and 
reproduces along with the host, creating a symbiotic relationship that in some cases results 
in mutualism, where the prophage, the integrated phage, provide fitness and evolutionary 
advantages to the lysogenic bacterium until the lytic cycle is induced (Ackermann, 1987; 
Weinbauer, 2004). 
Figure 6. Families in the order of Caudovirales. (Harper et al., 2011)  
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Figure 7. Bacteriophage Lifecycle: Lytic phages attach and infect a bacterial cell which results in the 
reproduction of phages and lysis of the cell host and the lysogenic cycle results in the integration of 
a phage genome into the bacterial genome. Some lysogenic phages do not integrate into the genome 
and remain in the cell as a circular or linear plasmid (not depicted here) (Batinovic et al., 2019). 
The life cycle of a phage is separated into several stages: adsorption, separation of nucleic 
acids from protein coat, expression and replication of the nucleic acids, virion assembly, 
release, and transmission (Duckworth, 1987). Virion adsorption on host cell surface is 
usually explained as the process involving 2 stages: reversible and irreversible binding. The 
initial step of adsorption to a cell surface is reversible presenting an opportunity for phage 
to progress to an infection or remain dormant. During the second stage, the adsorption of 
phage is an irreversible binding between bacterial surface receptors and phage tail fibres. 
Subsequently, phage enzymes make the cell wall penetrable and the genetic material is 
injected into the cell. At this stage, the injected phage genetic material can either remain in 
the cytoplasm or be incorporated into the host genome. However, for all viruses, there is a 
stage where the injected phage genetic material is not integrated into the host genome but 
exists within the cytoplasm of the host cell. This is the stage where genomes, tails and 
capsids are formed before the genomes are packaged into the capsids, genome replication, 
and gene expression occurs (Weinbauer, 2004). There are 3 stages that describes the life 
cycle of phages from adsorption to cell lysis: the latent period where no phage is seen 
outside the host genome; the eclipse period where matured phages are assembled from 
genomes and capsids; and the rise period where the mature phages are released by cell 
lysis (Rakhuba et al., 2010; Weinbauer, 2004). Phages and bacteria have coevolved in a 
fierce arms race that has involved the development of strategic defence mechanism {such 
as the restriction-modification system; CRISPR (clustered regularly interspersed 
palindromic repeats) and the abortive infection system} by bacteria and the phage 
counterattack with restored infectivity. 
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1.6  Phage evolution 
The evolution of bacteriophages has been attributed to different mechanisms including DNA 
replication errors, environmental mutagens and HGT mechanisms. The large diversity seen 
among bacteriophages comes from single point mutations occurring during genome 
replication. These minimal rate mutations are then integrated into phage offspring’s 
(Eriksson, 2015, Duffy et al., 2008). 
In a process called recombination, DNA is easily integrated into genomes by exchanging or 
recombining of genetic material, whilst in prokaryotic cells, genetic materials are exchanged 
through HGT mechanisms and in some cases the integrity of the genome is preserved 
through DNA repair mechanisms. In general, 4 types of naturally occurring recombination 
have been described: homologus, non-homologous, site-specific, and replicative 
recombination (Eriksson, 2015).  
The ever-evolving coexistence of phages and bacteria is responsible for bacteria 
diversification. Phages contribute through lysogenic conversion or transduction, to the HGT 
between microbial genomes. The three classical mechanisms for HGT in prokaryotes are 
transformation, conjugation, and transduction. Historically, conjugation and transformation 
were the major contributors to bacterial HGT, however transduction plays important roles in 
the transfer of antibiotic resistance genes and in the acquisition of novel genes during intra-
specific bacterial competition. The characteristics of transduction and lysogenic conversion 
complement those of other mechanisms of transfer and could play a key role in the spread 
of adaptive genes between communities (Schneider, 2017; Touchon et al., 2017). 
1.7 Bacterial defence system against phages 
In the different stages from when phages adhere to the cell, to when they are assembled 
and released into the environment, bacteria have developed mechanisms to defend against 
phage infection at every stage (Figure 8). This bacterial defence system against phage 
invasion can be categorised into three: adsorption inhibition, restriction, and abortive 
infections (Hyman and Abedon, 2010). 
1.7.1 Adsorption inhibition 
Adsorption inhibition is the primary defence mechanism of the bacteria. It does this by 
blocking the attachment and transfer of bacteriophage genome into bacteria host cell. The 
part of the bacterial cell wall that phages binds to is usually a conserved part of the cell wall. 
Phages can bind to different surface structures on the bacterial cell wall before adsorption, 
such an example is T5 phage binding to an outer membrane transport protein FhuA 
(Flayhan et al., 2012). Some systems of adsorption inhibition include bacterial surface 
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receptors which can become resistant to bacteriophages adsorption by changing the 
structure on their cell surface receptor thereby blocking phage receptors. This process 
ensures bacteria are protected from infection (Figure 8A). It can also lead to a process 
called superinfection exclusion (Sie) where host cells are granted immunity against 
subsequent infections by specific phages (Labrie et al., 2010); external polysaccharides of 
bacteria which can cover the cell in a capsule layer which is usually described as a virulence 
factor since it protects bacteria from phage infection and animal immune system. However, 
phages have developed the capability to digest these polysaccharide capsules; biofilm 
production where bacteria can provide alternative defence mechanisms by producing an 
outer protective polymer layer or biofilm which comprises of clusters of microorganisms, 
that can stick to surfaces such as epithelium in animals. (Hall-Stoodley et al., 2004). These 
polymer layer consist of different types of extracellular polymeric substances including 
proteins, lipids, DNA, and polysaccharides. These aggregates are physically joined, 
granting protection to these microorganisms against phages, antibiotics, and other 
environmental factors (Bjarnsholt, 2013). 
1.7.2 Restriction modification systems 
In what is seen as the secondary defence mechanism, bacteria can restrict the invasion of 
foreign DNA. Bacteria have developed several defence systems towards that goal including: 
the digestion of foreign DNA and the protection of the host DNA. The host DNA avoids 
restricting its own DNA by modifying it through methylation. Restriction - modification (RM) 
systems function to protect bacterial cells from invading foreign un-methylated DNA 
molecules. The RM systems are divided into several categories depending on enzyme 
composition and cofactor requirements, recognition sequence sites, and cleavage position. 
Found in 80 % of sequenced bacterial genomes, type II RM system is the most published 
in literature (Wilson and Murray, 1991). The RM systems comprises of a pair of opposing 
intracellular enzyme activities: a restriction endonuclease (REase) and a DNA 
methyltransferase (MTase), which interacts with specific nucleotide sequences in DNA. The 
REase explicitly marks and cuts double-strand DNA at certain nucleotide sequences, while 
the MTase methylates (adds one methyl group) cytosine or adenine residues in the same 
nucleotide sequence. The enzymes co-exist simultaneously at various molarity, with REase 
being the most abundant. Interestingly, phages have developed the capability to avoid 
digestion by RM systems, e.g., base modification to prevent recognition, DNA masking and 
endonuclease blocking (Samson et al., 2013). 
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1.7.3 CRISPR-Cas 
The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-
associated proteins) are found in many bacteria and the CRISPR-Cas system provides 
adaptive immune system to prokaryotes by integrating plasmid and viral DNA fragments in 
loci of CRISPR on host chromosome (Westra et al., 2012a, Wiedenheft et al., 2012). This 
is a defensive method that functions in three stages: adaptation, expression, and 
interference. During the adaptation phase, resistance is acquired by integrating foreign DNA 
into the CRISPR array. During the expression phase, cas genes are transcribed and 
translated whilst during the interference stage, cas proteins cleave complementary nucleic 
acids conferring immunity against a subsequent infection by a phage with an identical 
sequence to the acquired DNA (Westra et al., 2012b, Swarts et al., 2012). The CRISPR 
array, keeps track of prior infections experienced by the cell. When viruses infect the cell 
for the first time, the specific Cas proteins cleave the invading genetic material and introduce 
the resulting snippets into a CRISPR array. These snippets are used to recognize a second 
invasion from the same phage and to promptly inactivate the invading DNA/RNA (Richter, 
et al., 2012). The CRISPR-cas system is divided into three subtypes: type I, II and III. This 
classification was made based on signature genes present in each type and each type uses 
a unique set of Cas proteins along with CRISPR RNAs (crRNA) for CRISPR 
interference(Shabbir et al., 2019). In contrast to the type I and type III systems that utilize a 
large multi-Cas protein complex for crRNA binding and target sequence degradation, type 
II CRISPR systems uses a unique DNA endonuclease, Cas9, to recognize dsDNA 
substrates and cleave each strand with a distinct nuclease domain (Jiang and Doudna, 
2017; Hille and Charpentier, 2016). During this silencing process, an additional small 
noncoding RNA, called the trans-activating crRNA (tracrRNA), base pairs with the repeat 
sequence in the crRNA to form a unique dual-RNA hybrid structure. This dual-RNA guide 
directs Cas9 to cleave any DNA containing a complementary 20-nucleotide (nt) target 
sequence and adjacent protospacer adjacent motif (PAM) (Jiang and Doudna, 2017). 
Bondy-Denomy et al., 2013 observed that Pseudomonas aeruginosa temperate phages 
using the crRNA/Cas complex could overcome restriction by the CRISPR-Cas system by 
cleaving foreign DNA molecules at sites complimentary to the crRNAs, thus granting 
resistance to phages and other invading DNA molecules. 
1.7.4 Abortive infection 
Abortive infection (Abi) is a bacterial defence mechanism employed by bacteria against 
phages to initiate autolysis or cause cell to arrest phage infection cycle. This process 
decreases, or eradicates, production of phage progeny and protects bacterial population by 
an act like known as “altruistic suicide” where infected bacterial cells die abruptly (Figure 
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8C). It can be facilitated by toxin-antitoxin (TA) systems. Different types of Abi systems have 
been published with their principle of operation reliant on a single gene. Most are domiciled 
on plasmids with some exceptions where Abi system is part of the bacterial genome 
(Samson et al., 2013, Eriksson, 2015).  
 
Figure 8. Bacterial phage defense mechanisms. A) Adsorption inhibition, B) Restriction, C) 
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1.8 History of phages and phage therapy 
Traditionally, the discovery of bacteriophages is traced to the papers of Twort and D'Hérelle. 
However, earlier studies suggested the presence of phage like antibacterial activity. One 
such was reported in 1896 by Ernest H. Hankin in the Jumna and Ganges rivers. The British 
chemist described the first inkling that phages existed, when he discovered the potential of 
these waters to stop the spreading of cholera in the villages close to the rivers (Abedon et 
al., 2011). Not until 1915 when British bacteriologist Frederick Twort published an article in 
the renowned journal “Lancet” describing the existence of a glassy, transparent material 
that grew in Micrococci cultures. It was however not apparent if it was a virus, an enzyme 
produced by the same bacteria, or a small bacterium. At that time, it was difficult to obtain 
proof of their existence as pathogenicity towards higher organisms was the only evidence 
available of the presence of an “ultra-microscopic virus” (Twort, 1915).  
Two years later, in 1917, the French-Canadian Félix D’Herelle coined the name 
‘bacteriophages’ for these infectious agents lysing bacteria, when he discovered invisible 
microbe that was present in the bacteria-free filtrates of stool samples from dysentery 
patients (Roux, 2011; Summers, 2001).  D’Herelle was credited with developing the idea of 
‘phage therapy’, a therapeutic and prophylactic treatment aimed at taking advantage of 
phage selectivity in the cellular destruction of pathogenic bacteria while remaining 
completely innocuous to host cells. D’Herelle's approach led to a lot of international success 
where phages were used to treat dysentery in Brazil, Senegal, Egypt while the impact of 
phage against typhoid and paratyphoid were studied in Britain, Italy, and Greece. In USA, 
anti-staphylococcal phage suspensions were produced and distributed to many hospitals 
and during World War II, phage therapy was used by the German army (Fruciano and 
Bourne, 2007). Bacteriophage therapy was widely used around the world in the 1930s and 
1940s to treat various infections.  
However, the lack of understanding in phage biology, a lack of knowledge in phage 
specificity, the use of single type of phage to treat bacterial infection, improper phage 
preparation leading to phage inactivation, led to controversies around their effectiveness. 
With the introduction of antibiotics, commercial production of therapeutic phages stopped 
in most of the Western world. However, in some Eastern European countries and in the 
former Soviet Union, therapeutic phages have continued to be used instead or as an 
adjuvant with antibiotics. “Two such institutions actively involved in therapeutic phage 
research and production were, the Eliava Institute of Bacteriophage, Microbiology, and 
Virology (EIBMV) of the Georgian Academy of Sciences, Tbilisi, Georgia, and the Hirszfeld 
Institute of Immunology and Experimental Therapy (HIIET) of the Polish Academy of 
Sciences, Wroclaw, Poland” (Sulakvelidze et al., 2001; Semler et al., 2012). 
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1.9 Mechanism of Phage Therapy 
The idea of using phage therapy to treat clinical infection involves three basic steps. Firstly, 
the root cause of the infection must be determined. The causative agent must be isolated 
and characterized to evaluate the sensitivity of the strain. Secondly, a phage cocktail 
preparation, preferably with a high titer of a variety of host receptors effective against the 
corresponding strain, must be made. Finally, at the localised site of infection, this phage 
preparation must be administered correctly to the patient (Semler et al., 2012, Bradbury, 
2004). According to published literature, phage preparation can be administered in several 
ways including oral, rectal, topical, intravenous, and via an aerosol (Sulakvelidze and 
Morris, 2001). 
The pharmacokinetics of phage treatment are unique in relation to any medication presently 
utilized. An example is the inverse relationship seen with a chemical drug where 
concentration decreases after initial administration. The reverse is valid for phage treatment 
where the dosage of phage preparation administered is increased until the infection is 
cleared, because the initial phage dosage replicates. This is known as active phage therapy 
whilst a situation where the initial phage dose administered is effective enough in clearing 
the infection without replicating is known as passive phage therapy (Payne and Jansen, 
2003). While it is untrue to suggest that all that is required for a successful active phage 
therapy is a low phage titer preparation, Payne and Jansen (2003) using a numerical model 
mimicking the pharmacokinetics of phage treatment observed that bacterial density of the 
infection is key in choosing the appropriate concentration needed for a successful 
treatment. They argued that a less dense bacterial population could not support an active 
phage therapy because phages would be unable to replicate rapidly enough to yield and 
sustain the high concentrations that are needed to maintain a high bacterial mortality rate. 
However, in situations like this, to entirely clear the infection high titer phage preparation 
must be administered, in a similar plan to antibiotic therapy (Levin and Bull, 2004).  
In summary, wastewater is a large reservoir of microorganisms with antibiotic resistance 
genes and have become increasingly significant in the spread of multi-drug resistant 
microbes. Although the focus has been put in limiting the spread through creation of 
wastewater treatment plants where effluent is recycled for use in the environment, this can 
also serve as a route of infection to humans with the effluent thought to be a hotspot for 
antibiotic resistance genes. The spread of infections caused by ESBL producing bacteria 
have added to the already increasing financial burden of healthcare providers.  Increased 
duration of hospital stays, prolonged treatment and additional nursing requirements all 
contribute to the increased costs of patient care. In addition to the increased cost to the 
NHS, the spread of ESBL producing bacteria within the hospital and community settings 
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has been one of the most significant epidemiological challenges in recent years, increasing 
predicaments for clinicians due to limited treatment options. Reduction in treatment options 
has forced carbapenems, particularly meropenem, to be the treatment of choice, however 
resistance because of overuse of this agent is also a concern. The application of 
bacteriophages to control microbial populations in environmental situations has been used 
successfully in medicine and food technology industries. The control of ESBL-producing 
bacteria is likely to be an important consideration in the future of multiple drug resistant 
pathogen control.  
1.10 Statement of aims and objectives. 
This project aims to contribute towards the expansion of different varieties of bacteriophage 
cocktails that can be used to kill pathogens in treated wastewater. The specific aim of this 
project is to isolate and characterize bacteriophages targeting different bacteria, which may 
be producing Extended Spectrum Beta-Lactamase (ESBL). These bacteria exhibit 
resistances to a wide variety of modern antibiotics making them difficult to eradicate. 
Specific objectives of the investigation are as follows:  
• Collection of water samples from Petersfield water plant for isolation of ESBL 
producing bacteria. 
• Identification and characterisation of environmentally ESBL producing bacteria for 
isolation of bacteriophages. 
• Isolation and characterisation of bacteriophages targeting specific bacteria strains, 
which may show antibiotic resistance because of ESBL production.  
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2.0 Materials and Methods 
 
2.1 Media preparation 
Different media were used in this study. LB medium was used for initial growth of 
environmental samples, for morphology study of isolated bacterial colonies and for 
preparation of serial dilution of the samples. LB agar was used for growth of isolated 
bacteria and counting of live bacteria when studying their growth. Mueller-Hinton agar was 
used for antimicrobial susceptibility, ESBL and AmpC production tests. Tryptone soy broth 
(TSB) and Tryptone soy agar (TSA) were used for bacterial growth for extended 
biochemical test. Media composition and preparation were as follows: 
2.1.1 LB medium 
Tryptone (10 g), Yeast Extract (5 g) and NaCl (10 g) (Fisher Scientific) were dissolved in 1 
L of dH2O, adjusted the pH to 7.0 and autoclaved at 121°C for 15 min. 
2.1.2 LB agar 
Agar Bacteriological (15 g) (Fisher Scientific) was added to 1 L of LB medium and 
autoclaved at 121°C for 15 min. The LB agar was chilled to 60°C in a water bath and 
approximately 25 ml poured into each Petri dishes. 
2.1.3 Mueller-Hinton Agar 
Mueller-Hinton Agar (38 g) (Fisher Scientific) was added to 1 L dH2O and autoclaved at 
121°C for 15 min. The medium was chilled up to 60°C in a water bath and approximately 
25 ml was poured into each Petri dishes. 
2.1.4 Tryptone soy broth 
TSB (30 g) (Fisher Scientific) was added to 1 L of dH2O and autoclaved at 121°C for 15 
min. 
2.1.5 Tryptone soy agar 
TSB (30 g), Agar Bacteriological (15 g) (Fisher Scientific) were added to 1 L dH2O and 
autoclaved at 121°C for 15 min. The TSB agar was chilled to 60°C in a water bath and 
approximately 25 ml poured into each Petri dishes. 
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2.1.6 Soft agar 
Agar Bacteriological (0.6 g) (Fisher Scientific) was added to 100 ml of LB medium and 
autoclaved at 121°C for 15 min. The soft agar was chilled up to 47°C in a water bath and 3 
ml was used for the overlay technique (page 38).  
2.1.7  Bacteriophage buffer 
Ten ml of 1M Tris-HCl (pH 7.5), twenty ml of 5M NaCl, ten ml of 1M MgSO4. 7H2O was 
added to 960 ml of sterile dH2O.  
2.2 Strains used in this study 
Seventeen bacterial strains were used in this study (Table 2). Twelve were isolated from 
water samples obtained from the Petersfield water plant while 5 were obtained from the 
University of Portsmouth culture collection. 
Table 2. Strains used in this study. 
Strains used in the study Sources 
EwS1  
Isolated from water samples EwB2 
*E. coli (strains 1-6) 
*Pseudomonas (strains 1-4) 
Serratia marcescens ATCC 17 AW  
Laboratory culture collection Hafnia alvei UoP culture collection 
Klebsiella pneumonia ATCC 13883 
E. coli K802 
Proteus mirabilis ATCC 7002 
* Shows E. coli and Pseudomonas strains isolated from wastewater.  
2.3 Collection of water samples and bacterial enrichment 
Environmental samples were collected from water treatment tank (site 4) from the 
Petersfield Water Treatment plant Hampshire, UK (Figure 9). The samples (100 ml) were 
collected into a sterile plastic container, packaged, and transported to the laboratory for 
bacteriological analysis in accordance with the Carriage of Dangerous Goods and Use of 
Transportable Pressure Equipment Regulations 2009. The samples for bacterial 
enrichment were diluted 1:50 with LB medium (Bertani, 2004) and were cultured under 
aerobic conditions for 4 hr at 30°C. 
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2.4 Isolation of extended spectrum beta lactamase producing 
bacteria 
Ten times serial dilution of the enriched samples were prepared and used for isolation of 
extended spectrum beta lactamase (ESBL) producing bacteria by spreading of 200 µl onto 
Figure 9. Schematic view of Petersfield Water Treatment plant. Untreated Effluent enters at Site 0 and is 
screened. Water containing more dense particles removed and taken underground to Site 1 for sludge 
processing independent from the rest of the plant. The remaining water moves through a pipe where ferric 
sulphide is added. The large volume of water is split in half into site 2 and site 3, for ease of processing 
before it is moved to the start of a series of trickling filters. The contaminated water is spread, via 
mechanical rotating arms, over basins containing large stones. Aeration of the water favours the 
breakdown of organic materials as it is passed over biofilms present on the gravel. Water is then passed 
through a holding tank (Site 4) before ejection into the surrounding environment. The reed beds are used 
to handle overflow, resulting when the rainfall is heavy. This provides some treatment before the water is 
released. 
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chromogenic medium (Oxoid Brilliance ESBL Agar).  The plates were sealed and incubated 
inverted at 30°C for 48 hr. For further purification, the colonies with different colour and 
morphology were picked up with a sterile loop, re-streaked onto fresh chromogenic medium. 
Sealed and inverted plates were incubated at 30°C for 48 hr.  
2.5 Identification and characterization of ESBL producing bacteria 
using microbiological techniques  
2.5.1 Antimicrobial susceptibility test 
Antimicrobial susceptibility test was carried out according to British Society for Antimicrobial 
Chemotherapy (BSAC) guidelines (Wootton, 2013). Bacterial colony was suspended in 5 
ml of nuclease-free water (Sigma) and the optical density was adjusted to 0.5 McFarland 
standard by comparing the test and standard suspensions against a white background with 
a contrasting black line (Wootton, 2013). The inoculum (200 µl) was evenly plated over 
Mueller-Hinton Agar (Fisher Scientific) using sterile spreader. After inoculation, antibiotic 
discs contaning Amoxicillin (10 μg/ml), Amoxicillin-clavulanic acid (30 μg/ml), Meropenem 
(10 μg/ml), Cefotaxime (30 μg/ml), Ertapenem (10 μg/ml), Ceftazidime (10 μg/ml), Cefepime 
(30 μg/ml), Tigecycline (15 μg/ml), Amikacin (30 μg/ml), Gentamicin (10 μg/ml), Ciproflaxcin 
(1 μg/ml), Piperacilin-tazobactam (75/10 μg/ml), and Cefuroxime (30 μg/ml) (all Fisher 
Scientific), were evenly spaced on the plates. After 24 hr incubation at 30°C, the results 
were interpreted by measuring diameters of the zone of inhibition in millimetres (Figure 10) 
and comparing with acceptable zone diameter breakpoints for Enterobacteriaceae 
(Wootton, 2013). Bacteria were classified as sensitive, intermediate demonstrating low level 
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2.5.2 ESBL and AmpC production 
ESBL producing microorganisms can be resistant to AmpC or have both AmpC and ESBLs 
resistance. To differentiate between these alternatives, the ESBL and AmpC disc diffusion 
test (MAST Group Ltd) was performed (Derbyshire et al., 2009). This method uses four test 
discs (A - cefpodoxime, B - cefpodoxime plus an ESBL inhibitor, C - cefpodoxime plus an 
AmpC inhibitor and D - cefpodoxime plus ESBL and AmpC inhibitors).  Single bacterial 
colony was suspended in 5 ml of nuclease-free water (Sigma) and the optical density was 
adjusted to 0.5 McFarland standard according to BSAC guidelines (Wootton, 2013). Each 
inoculum (200 µl) was evenly spread over the Petri dishes with Mueller-Hinton Agar and 
four identification discs were placed onto the agar plate. The plates were incubated at 30°C 
for 24 hr. Calculation of zone of inhibition diameters of each of the four discs identifies the 
ESBL, AmpC or both ESBL and AmpC determinants in isolates (Figure 11). The results 
were determined and interpreted by using the MAST ESBL calculator spreadsheet version 




Figure 10. Schematic diagram of the results of antibiotic sensitivity test.  Creamy coloured area is 
bacterial lawn and A, B and C are antibiotic impregnated disks.  A - bacteria are susceptible to an 
antibiotic, B - resistant to an antibiotic, C – bacteria have intermediate resistance to an antibiotic. 
The diameters of zones of inhibition are measured to the nearest millimetre (zone edge should be 
taken as the point of inhibition as judged by the naked eye) with a ruler. These zones can have 
different sizes for different antibiotics.  
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2.5.3 Identification of isolated ESBL producing bacteria using API 
20 E strip test. 
The API 20 E system (Biomerieux) uses a standard principle of assessing the enzymatic 
and metabolic activities that are specific for bacteria belonging to Enterobacteriaceae. The 
inoculum was prepared by suspending single bacteria colony in 5 ml of 0.9 % NaCl solution, 
the optical density (OD) was adjusted to 0.5 McFarland standard according to BSAC 
guidelines (Wootton, 2013). The inoculum was evenly distributed within the 20 cupules of 
the API 20 E strip; ensuring that wells arginine dihydrolase (ADH), lysine decarboxylase 
(LDC), ornithine decarboxylase (ODC), sodium thiosulfate (H2S) and urea (URE) were 
sealed with mineral oil due to the requirement for anaerobic conditions and sodium pyruvate 
and gelatine (VP and GEL) wells were filled completely. The strip was incubated at 30°C 
for 24 hr. After incubation, tryptophan deaminase (TDA reagent), Indole (James reagent) 
and VP (VP1 and VP2 reagents) were added into the cupules for TDA, IND and VP, 
respectively. The colour changes in cupules were registered and converted into a seven-
digit code using the APIWEB data base (Biomerieux), available at 
Figure 11. Schematic diagram for calculation of bacterial growth inhibition zone discs for 
determination of antibiotic resistance type. The above calculation corresponds to bacteria 
having an ESBL resistance only as the zone diameter of Disc B – zone diameter of Disc A 
and zone diameter of Disc D – zone diameter of Disc C was ≥ 5 mm and the difference of 
each zone diameter of Disc B – zone diameter of Disc D and zone diameter of Disc A – zone 
diameter of Disc C was < 4 mm. 
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https://apiweb.biomerieux.com. This code can then be converted to a bacterial 
identification. 
2.5.4 Biolog GEN III extended Biochemical test 
Biolog GEN III (BIOLOG) is a single 96- well microplate consisting of 94 biochemical tests: 
71 carbon sources and 23 chemical sensitivity assays. All microplates were inoculated 
according to the protocol A. Overnight bacteria cultures grown in tryptone soy broth were 
streaked onto tryptone soy agar plates and incubated for 48 hr. A single bacterial colony 
was picked up using a sterile swab and carefully mixed with “inoculating fluid IF-A”. The 
turbidity was adjusted to a range of 90 – 98 % transmittance at 590 nm by addition of more 
cells if cell density was too low or inoculating fluid, if density was too high. Each microplate 
well was inoculated with 100 µl of the cell suspension. After 22 hr of incubation, the colour 
intensities in wells were observed and recorded as positive in wells having a noticeable 
purple colour, borderline in wells having a faint purple colour or negative if no colour 
developed. This well colour development was imaged and sent to BIOLOG for Interpretation 
using a specialised software and these substrate-utilization profiles were compared with the 
Biolog software database for identification of the bacteria (BIOLOG). 
2.5.5  Growth of isolated bacteria at different temperatures 
A total of 8 flasks (250 ml) were used in this experiment. Each flask contained 50 ml of LB 
broth inoculated with overnight bacterial culture with at the ratio 1:10. For this experiment, 
the medium was prewarmed and the cultures were grown overnight before inoculation at 
the temperature to be used for the experiment. Each flask was incubated at its desired 
temperature of +5°C, +10°C, +15°C, +22.5°C, +25°C, +30°C, +32°C, +37°C with aeration 
at 150 rpm (SciQuip Incu-Shake MAXI). Each hour of the first 10 hr of incubation, 1 ml of 
culture was taken under sterile condition for optical density (OD) measurement at 600 nm 
using a spectrophotometer (Thermo Scientific Helios Epsilon). A ten times serial dilution 
down to 10-7 was made and from each dilution 100 µl was plated on LB agar for counting of 
living bacterial cells. All experiments were run in triplicate. Growth curves were made by 
plotting the OD values against temperatures. 
2.6 Identification and characterization of ESBL producing 
bacteria using molecular biology techniques. 
2.6.1 Purification of Genomic DNA  
Total bacterial DNA was purified using the DNeasy Blood and Tissue kit (Qiagen®) 
according to the manufacturer’s instruction. The bacterial cells were incubated overnight in 
5 ml of the LB at 30°C in a shaking incubator at 150 rpm (SciQuip Incu-Shake MAXI). Three 
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ml of cultures was harvested by centrifuging for 10 min at 5000 x g. The pellet was 
suspended in 180 μl Buffer ATL. 20 μl of Proteinase K (600 mAU/ml) was added, sample 
vortexed, incubated at 56°C for 1 hour 30 min. The suspension was then vortexed 
thoroughly for 15 sec. 200 μl of Buffer AL (lysis buffer) mixed with ethanol (96%) was added 
and thoroughly mixed. The mixture was transferred to the DNeasy Mini spin column and 
centrifuged for 1 min at ≥6000 x g. The column was consequently washed with 500 μl Buffer 
AW1, then with 500 μl Buffer AW2 and centrifuged for 3 min at 20000 x g to dry the 
membrane. DNA was eluted from the membrane with 100 μl Buffer AE into a fresh tube. 
DNA concentration and quality were estimated spectrophotometrically (NanoDrop, 
Technologies Inc.). The stock solution of DNA for PCR reactions was prepared to make a 
final concentration of 5 ng/µl.  
2.6.2 Purification of Plasmid DNA  
Plasmid DNA from bacterial cells was purified using the Zyppy miniprep kit (ZYMO 
Research) according to manufacturer’s manual. Briefly, 3 ml of overnight bacterial culture 
was centrifuged for 90 sec at 16000 x g. The pellet was suspended in 600 μl of sterile dH2O. 
100 μl of 7X Lysis Buffer was added and mixed thoroughly. Complete lysis was confirmed 
by the change of colour of the suspension from opaque to clear blue. Cold Neutralization 
Buffer (350 μl) was added and the suspension mixed thoroughly. The sample turns yellow 
when the neutralization is completed. The suspension was centrifuged for 4 min at 16,000 
x g, the supernatant transferred into the Zymo-Spin™ IIN column and centrifuged for 15 sec 
at 16,000 x g. The column was washed with 200 μl of Endo-Wash Buffer, then with 400 μl 
of Zyppy™ Wash Buffer. The column was transferred into a clean microcentrifuge tube and 
DNA was eluted with 30 μl of elution buffer. DNA concentration and quality were estimated 
spectrophotometrically (NanoDrop, Technologies Inc.) and analysed by electrophoresis in 
1 % agarose gels. 
2.6.3 Multiplex PCR Amplification of TEM, CTX and SHV genes 
Plasmid and chromosomal DNA were used for multiplex PCR amplification with 3 sets of 
primers to detect TEM, CTX, SHV genes (Monstein et al., 2007). Multiplex PCR reactions 
were set up using 12.5 μl of 2x GoTaq® G2 Hot Start Green Master Mix  (Promega, UK), 1 
µl (10 µM) of each forward and reverse primer (Table 3) and 6.5 µl of bacterial DNA (5 ng/µl) 
in a final volume of 25 µl. PCR amplification conditions were as follows: initial denaturation 
step at 95°C for 5 min; 30 cycles of denaturation at 95°C for 30 s, annealing at 54°C for 30 
s, extension at 72°C for 2 min, followed by a final extension step at 75°C for 10 min using 
the T100TM Thermal Cycler (Bio-Rad). The PCR products were analysed by 
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electrophoresis in 1.2 % agarose gels and documented using molecular imager® Gel Doc™ 
XR+ imaging system (Bio-Rad). 
 
 
Table 3. Primer sequences for PCR amplification of 16S rRNA gene and multiplex PCR analysis of 
CTX, TEM, SHV, and OXA group I, II, III genes.  (Monstein et al., 2007; Bert et al., 2002). 
Primer Name Sequence 5’ to 3’ Amplicon 
Size (bp) 
BlaCTX Forward ATGTGCAGYACCAGTAARGTKATGGC  
593 
BlaCTX Reverse TGGGTRAARTARGTSACCAGAAYCAGCGG 
BlaTEM Forward TCGCCGCATACACTATTCTCAGAATGA  
445 
 BlaTEM Reverse ACGCTCACCGGCTCCAGATTTAT 
BlaSHV Forward ATGCGTTATATTCGCCTGTG  
747 
 BlaSHV Reverse TGCTTTGTTATTCGGGCCAA 
OXA Group 1 
Forward 
TCA ACA AAT CGC CAG AGA AG  
276 
OXA Group 1 
Reverse 
TCC CAC ACC AGA AAA ACC AG 
OXA Group 2 
Forward 
AAG AAA CGC TAC TCG CCT GC  
478 
OXA Group 2 
Reverse 
CCA CTC AAC CCA TCC TAC CC 
OXA Group 3 
Forward 
TTT TCT GTT GTT TGG GTT TT  
427 
OXA Group 3 
Reverse 
TTT CTT GGC TTT TAT GCT TG 
8F AGA GTT TGA TCC TGG CTC AG  
1500 
1492R GGT TAC CTT GTT ACG ACT T 
 
2.6.4 Multiplex PCR Amplification of OXA group genes 
DNA from purified bacterial cells were used for multiplex PCR amplification with 3 sets of 
primers to detect OXA groups I, II, III genes (Bert el al., 2002). Multiplex PCR reactions 
were set up using 12.5 μl of 2x GoTaq® G2 Hot Start Green Master Mix (Promega), 1 µl 
(10 µM) of each forward and reverse primer (Table 3) and 6.5 μl of bacterial DNA (5 ng/µl) 
in a final volume of 25 µl. The template DNA was amplified using T100TM Thermal Cycler 
using the same cycling conditions as described for TEM, CTX and SHV multiplex PCR. The 
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PCR products were analysed by electrophoresis in 1.2 % agarose gels and documented by 
molecular imager® Gel Doc™ XR+ imaging system (Bio-Rad).  
2.6.5 PCR amplification of the 16S rRNA gene 
Total genomic DNA was used for PCR amplification of 16S rRNA gene. PCR reactions were 
set up using 10 μl of bacterial DNA (5 ng/µl), 1 μl (10 μM) of each forward and reverse 
primer (Table 3) (Turner, 1999) and 12.5 μl 2x GoTaq Green master mix (Promega) and 
0.5 μl of nuclease-free water (Sigma) in a final volume of 25 µl. PCR amplification conditions 
were as follows: initial denaturation step at 94°C for 2 min; 30 cycles of denaturation at 94°C 
for 1 min, annealing at 55°C for 1 min, extension at 72°C for 45 s followed by the final 
extension step at 72°C for 15 min (Lane, 1991) using the T100TM Thermal Cycler (Bio-Rad, 
UK). The PCR products were analysed by electrophoresis in 1.2 % agarose gels and 
documented using molecular imager® Gel Doc™ XR+ imaging system (Bio-Rad).  
2.6.6 Preparation of agarose gels for electrophoresis 
Agarose gels 1-1.2 % (Sigma) were made by mixing the required amount of agarose with 
100 ml of 1 x Tris-acetate EDTA (TAE) buffer and melted using a microwave. The ends of 
the gel tray were sealed with small amount of agarose and the rest of the molten agarose 
was cooled down to 50°C, 6 μl of SYBR® safe DNA gel stain (Invitrogen) was added and 
all poured into a gel tray, a comb was inserted, and gel was left to solidify. The tray was 
placed into a gel box and covered with 1 x TAE buffer and the comb was removed. Promega 
1 kb DNA ladder (8-10 μl) and samples were loaded. Gels were typically run at 150 volts 
for 1 hour and 15 min. The PCR products on the gels were visualised under UV light and 
images captured using molecular imager® Gel Doc™ XR+ imaging system (Bio-Rad).   
2.6.7 Sequence analysis of the 16S rRNA gene 
PCR products of amplified 16S rRNA gene were cleaned up using QIAquick PCR 
purification kit (QIAGEN) according to manufacturer’s instructions. Briefly, five volumes of 
Buffer PB were added to 1 volume of the PCR sample. The mixture was added to a 
QIAquick spin column to bind DNA to the column membrane and centrifuged for 30–60 sec 
at 17,900 x g. The column was washed with 0.75 ml Buffer PE and centrifuged for 30–60 
sec at 17,900 x g. The column was centrifuged for an additional 1 min at 17,900 x g to dry 
the membrane and placed into a clean tube. Fifty μl of nuclease-free water (Sigma) was 
added to the centre of the QIAquick membrane, left for 1 min at room temperature and DNA 
was eluted by centrifugation for 1 min at 17,900 x g. DNA concentration and quality were 
estimated spectrophotometrically (NanoDrop, Technologies Inc.). DNA solution (30-40 µl) 
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(10-50 ng/µl) was sent for sequencing (GATC Biotech Ltd). DNA sequences obtained were 
confirmed using the nucleotide BLAST program. 
2.6.8 Whole Genome Sequencing  
Whole genome sequencing was performed by MicrobesNG. Overnight culture was streaked 
out on a LB agar plate to cover around 1/3 of the plate with a lawn of bacteria. After 
incubation at 30°C for 48 hr, using sterile loop all bacteria were taken off the plate and 
added into the barcoded bead tube supplied by MicrobesNG. The content was mixed by 
inverting 10 times, tubes packed, and sent off immediately for sequencing. 
2.6.9 Sequence and Phylogenetic Analyses 
Sequence alignments were generated for 16S rRNA genes representing 53 taxa, and for 
the suc A, pyr G, rpo B, rpl B and fus A genes for 46 taxa using the MUSCLE (Multiple 
sequence alignment) programme (Edgar, 2004). An additional alignment was produced for 
a combination of 4 genes (suc A, pyr G, rpo B, and rpl B) using the sequence editor 
implemented in the SEAVIEW programme (Gouy et al., 2009). Parsimony analysis was 
performed on the 16S rRNA sequence matrix using PAUP 4.1 (Swofford, 2002), and the 
maximum likelihood analysis performed on the housekeeping genes using PhyML (Zhou et 
al., 2017). Genome comparison was performed using OneCodex software and their 
genome library (https://onecodex.com/platform/), while gene annotation analysis was made 
using Artemis (Carver et al., 2011) and Genome Comparison software (Lederman, 2015). 
Genome sequence alignments were constructed using Mauve (Darling et al., 2004; Darling 
et al., 2010) implementing the HOXD scoring. Genomic islands for isolates EwS1 and EwB2 
were identified using the on-line programme IslandViewer 4 (Dhillon et al., 2013, Bertelli et 
al., 2017) using the complete genomic sequence for Rahnella aquatilis HX2 (NR_076967) 
as the reference.  
2.7 Isolation, identification, and characterization of 
bacteriophages 
2.7.1 Preparation of bacterial cells for bacteriophage propagation 
Discovered EwS1 and EwB2 bacteria isolated from wastewater were grown on agar plates 
and used in all experiments. Bacterial cultures for phage titer determination were prepared 
in vials (30 ml, Fisher Scientific) by inoculating a swab of bacterial culture into 5 ml LB and 
incubation with aeration (150 rpm, SciQuip Incu-Shake MAXI) at 30°C for 16-24 hr. For the 
procedure of bacteriophage inoculation, fresh bacterial cells in log phase were used. To 
achieve a multiplicity of infection (MOI) of 0.1, which is the number of virions that are added 
per cell during infection, the quantity of bacteria cells needed was 2.8-3.0 x 108 cfu/ml which 
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corresponds to absorbance 0.54–0.6 at 600 nm. Therefore, the bacterial cell overnight 
culture was inoculated with ratio 1:10 in LB and incubated with aeration at 30°C for 
approximately 4–41 2�  hr. Furthermore, for every experiment 1 ml aliquot was taken out for 
measurement of optical density and subsequent quantification of living bacterial cells to 
confirm the previous calculations. 
2.7.2 Bacteriophage enrichment and isolation of bacteriophages 
The water sample was filtered through 0.8 µm filter pore (Thermo Scientific) and the filtrate 
was centrifuged at 4,400 rpm (Awel MF 20-R) at 20°C for 1 hr and subsequently passed 
through 0.2 µm filter (Thermo Scientific) to obtain Cell-free supernatant (CFS). The CFS 
was used for enrichment of bacteriophages using isolated bacteria. Briefly, 5 ml of LB was 
inoculated with 50 µl of overnight bacterial culture and 0.9 ml of CFS. The vial was incubated 
overnight at 30°C with aeration at 120 rpm (SciQuip Incu-Shake MAXI). After enrichment, 
the mixture was centrifuged at 4,400 rpm (Awel MF 20-R) at 20°C for 1 hr and filtered using 
0.2 µm syringe filter pore (Elkay). A serial dilution (SD) from 10-1 to 10-5 was prepared. 
Bacteriophage buffer (4.5 ml) and 0.5 ml of CFS were added to the first universal vial, mixed 
thoroughly, and marked as SD-1. From the 1st vial (0.5 ml) was transferred into the 2nd 
bottle, labelled SD-2.  The same procedure was repeated until SD-5 was achieved. From 
each dilution (0.1 ml) mixed with 0.1 ml of bacterial overnight cultures and 3 ml of soft agar 
was poured onto bottom agar plate using overlay technique (Twenty-five ml of LB bottom 
agar were poured on Petri dishes. Soft agar was stored in 100 ml volumes, melted when 
required, and tempered to 47◦ C before use. Bacterial culture and bacteriophages were 
mixed in each overlay before pouring onto dried base plates. The soft agar was swirled to 
produce a uniform top layer and incubated at 30◦C for 24 hr before inspection for plaque 
formation) and incubated at 30°C overnight. Plaque counts in pfu/ml were calculated by 
taking the average number of plaques for a dilution and the inverse of the total dilution factor 
(Baer and Kehn-Hall, 2014). 
 
𝑝𝑝𝑝𝑝𝑝𝑝/𝑚𝑚𝑚𝑚 =
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝑛𝑛𝑝𝑝𝑚𝑚𝑛𝑛𝐴𝐴𝐴𝐴 𝑜𝑜𝑝𝑝 𝑝𝑝𝑚𝑚𝐴𝐴𝑝𝑝𝑝𝑝𝐴𝐴𝑝𝑝




2.7.3 Purification of bacteriophages 
Single plaques of bacteriophages with different plaque morphologies were picked up by 
stabbing sterile Pasteur pipettes through the selected plaque and into the hard agar 
beneath. An agar plug containing phage was transferred into 1ml of bacteriophage buffer, 
suspended, centrifuged at 14,800 rpm (Sigma 1-14 Micro Centrifuge) for 10 min and filtered 
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using 0.2 µm syringe filter. A ten times serial dilution down to 10-5 were prepared as 
described before and the bacteriophages were grown on agar plates using overlay 
technique (page 38). The plates were incubated at 30°C overnight. For each isolated phage, 
this step was repeated three times to obtain bacteriophages of the same morphology and 
used for further purification.  
2.7.4 Effect of CaCl2 and MgSO4 on the efficiency of 
bacteriophage growth 
These cations are needed for bacteriophage growth. A total of 6 flasks (250 ml) were used 
in this experiment. Each flask contained 50 ml of LB was inoculated with bacteria (2.8 x 108 
cfu) and bacteriophages (2.8 x 107 pfu) MOI 0.1. To the flasks were added 100 µl, 250 µl or 
500 µl of stock solutions of 1M CaCl2 or 1M MgSO4 to a final concentration of 2 mM, 5 mM 
and 10 mM of each salt. The flasks were incubated at +30°C with aeration at 150 rpm 
(SciQuip Incu-Shake MAXI) for 16-24 hr. After incubation, the samples were centrifuged at 
4,400 rpm (Awel MF 20-R) and filtered using 0.2 µm filters (Thermo Scientific). Serial 
dilution of the resulting CFS was prepared up to 10-7 and the bacteriophages were grown 
on agar plates using the overlay technique (page 38). 
2.7.5 Large Scale purification of bacteriophages  
(a)  from agar plates with confluent lysis  
Isolated bacteriophages were diluted serially in bacteriophage buffer to give a concentration 
that would provide confluent lysis for the isolated bacteria. 50 plates with almost confluent 
lysis were taken for phage purification. The soft agar layer scrapped from the base plate 
was transferred to a centrifuge tube, suspended in 5 ml of LB per plate and the contents 
were centrifuged at 4400 rpm (Awel MF 20-R) for 1 hr at + 4°C. The supernatant was then 
filtered through 0.2 µm filters (Thermo Scientific) into universal vials. The resulting CFS was 
serially diluted up to 10-7 and the bacteriophage titer was determined using the overlay 
technique. 
(b)  from liquid medium 
250 ml flask with 100 ml of LB was inoculated with a fresh bacteria culture (4.4 x 109 cfu) 
and bacteriophages (4.2 x 108 pfu) with MOI 0.1. CaCl2 (10 mM) was added and the flask 
incubated at 30°C with aeration at 150 rpm (SciQuip Incu-Shake MAXI) for 16-24 hr. After 
incubation, the samples were centrifuged at 4400 rpm (Awel MF 20-R), supernatants filtered 
through 0.2 µm pore-size filter (Thermo Scientific). The resulting CFS was serially diluted 
up to 10-7 and the bacteriophages were grown on agar plates using the overlay (page 38) 
and spot test techniques (Twenty-five ml of LB bottom agar were poured on Petri dishes. 
Soft agar was stored in 100 ml volumes, melted when required, and tempered to 47◦ C 
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before use. Bacterial culture (0.1 ml) was poured onto dried base plates and the soft agar 
was swirled to produce a uniform top layer and finally allowed to dry. Twenty µl of 
bacteriophage suspension from 10 times serial dilution was spotted on to the dried plate 
and incubated at 30◦C for 24 hr before inspection for plaque formation). 
 
2.7.6 PEG precipitation of Bacteriophage lysate  
Cell free supernatant (250 ml) was transferred into a new container. PEG6000 (Fisher 
Scientific) was added to a final concentration of 10% and NaCl was adjusted to 0.5 M. 
Samples were mixed gently by swirling the tubes to completely dissolve PEG6000 and NaCl 
and left overnight at 4°C. The bacteriophages were pelleted by centrifugation at 4,400 rpm 
(Awel MF 20-R) for 1 hr at 4°C. Supernatants were removed, pellets were re-suspended in 
bacteriophage buffer and subjected to dialysis. 
2.7.7 Dialysis of Bacteriophage lysate 
Prior to dialysis, the dialysis membrane was hydrated by immersing in dialysis buffer for 2 
min according to manufacturer’s instructions. The dialysis chamber (3 ml Slide-A-Lyzer 
dialysis cassette, Fisher Scientific) was loaded with phage concentrate to a minimum 
volume of half of the cassettes maximum volume. Phage concentrate was dialyzed against 
2 L of dialysis buffer at 4 °C on a stirring plate for 48 hr replacing the buffer solution three-
four times. Finally, phage concentrate was carefully collected using a sterile plastic pipette 
and phage titer was determined by serially diluting the concentrate up to 10-7 and the 
bacteriophages were grown on agar plates using the overlay technique (page 38). 
2.7.8 Transmission Electron Microscopy  
Prior to TEM, dialysed phage sample was transferred into microcentrifuge tube and 
centrifuged at 14000 rpm (Sigma 1-14 Micro Centrifuge) for 2 hr. The pellet was 
resuspended in 50 µl of TEM phage buffer. One drop (5 µl) of phage suspension was 
applied to the dark and shiny surface of a Formvar-carbon-coated copper grid (200 mesh) 
and allowed to sit for 2-10 min. The grid was rinsed by using 60 µl of sterile dH2O. Excess 
liquid was wicked off using filter paper. The grid was immersed in 2% uranyl acetate solution 
for 30 s, then passed through 3 tubes containing ultra-purified water (Fisher Scientific) with 
10 sec in each. Excess stain was immediately wicked off by using a wedge of filter paper. 
The grid was then placed in a grid box, allowed to dry overnight, then stored in a desiccator 
until analysis.  
Electron microscopic images of uranyl acetate stained phage were obtained by Prof. Cragg 
and Mrs. Christine Hughes using the JEM 2100 Transmission Electron Microscope (JEOL 
Ltd, Japan) operated at 80 kV.  Dimensions of virions were measured on micrographs at 
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magnification of 30,000 times and with a measuring magnifier, calibrated at 100 nm 
intervals.  
2.7.9 Host range determination of isolated bacteriophages  
To determine host range, all newly isolated bacteria, as well as Serratia marcescens, Hafnia 
alvei, Klebsiella pneumonia, E. coli K802, and Proteus mirabilis from the laboratory 
collection were used. Briefly, 5 ml of LB medium was inoculated with 50 µl of overnight 
bacterial culture and 0.9 ml of cell free supernatant (CFS). The vail was incubated overnight 
at 30°C with aeration at 120 rpm (SciQuip Incu-Shake MAXI). After enrichment, the mixture 
was centrifuged at 4,400 rpm (Awel MF 20-R) at 20°C for 1 hr and subsequently passed 
through 0.2 µm syringe filters (Elkay) to obtain CFS specific for that isolated bacteria. Serial 
dilution was made up to 10-6. From each dilution (0.1 ml) with 0.1 ml of bacterial overnight 
cultures and 3 ml of soft agar was poured onto bottom agar plate using the overlay 
technique (page 38). This stage was repeated for all isolated bacteria.   
2.7.10 Phage DNA isolation using the Phage DNA isolation kit.  
Bacteriophage DNA was purified using the Phage DNA isolation kit (Norgen) according to 
manufacturer’s manual. One ml of phage prepared from liquid culture was added into a 5 
ml vial, 1:100 of DNase I (10 mg/ml) and 1:200 of RNase A (10 mg/ml) were added, mixed, 
and incubated at 37°C for 30 min. Then 1:40 of 20% SDS and 1:100 of Proteinase K (10 
mg/ml) were added to the sample, mixed, and incubated at 37°C for 30 min. 500 µl of lysis 
buffer B was added and vortexed thoroughly, incubated at 65°C for 15 min and occasionally 
mixed during incubation by inverting the tube. Isopropanol (320 µl) was added and tubes 
vortexed briefly. The lysate (650 µl) was transferred to the phage DNA isolation column and 
centrifuged for 1 min at 6000 x g. This stage was repeated until the remaining lysate passed 
through the column. The column was subsequently washed three times with Wash solution 
A centrifuging for 1 min at 6000 x g. The column was centrifuged for 2 min 14000 x g to dry 
the resin membrane. DNA was eluted from the membrane with 75 µl of Elution buffer B. 
DNA concentration and quality were estimated spectrophotometrically (NanoDrop, 
Technologies Inc.). 
2.7.11 Phage DNA isolation by Phenol-chloroform extraction 
For bacteriophage DNA purification using phenol-chloroform. Phage supernatant (500 µl) 
was added into an Eppendorf tube, 1:100 of DNase I (10 mg/ml) and 1:200 of RNase A (10 
mg/ml) was added, mixed, and incubated at 37°C for 30 min. 1:40 of 20% SDS and 1:100 
of Proteinase K (10 mg/ml) were added to the sample, mixed and incubated at 37°C for 30 
min. The sample was transferred into a pre-centrifuged (30 sec at 16,000 x g) phase lock 
gel tube (Fisher Scientific), equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) 
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added, tubes vortexed or shaken by hand thoroughly. The mixture should turn milky. After 
5 min centrifugation at 16,000 × g the upper aqueous phase was carefully removed using a 
pipette and transferred to a fresh tube.  The above stage was repeated, and the aqueous 
phase was transferred into a clean Eppendorf tube. 1/10 volume of 3M sodium acetate and 
2.5 vol of 96 % ethanol (Fisher Scientific) was added to the DNA solution and left at -20°C 
overnight. After 10 min centrifugation at 4°C at 14000 rpm (Fisher, Heraeus fresco 21 
centrifuge) the supernatant was discarded. The pellet was washed three times with 1 ml of 
70 % ethanol, slightly dried and re-suspended with water. DNA concentration and quality 
were estimated spectrophotometrically (NanoDrop, Technologies Inc.). 
2.7.12 Phage DNA digestion with restriction enzymes 
Digestions of phage DNA were carried out using the appropriate buffer systems supplied 
with the enzymes. Briefly, the restriction mixture consists of 2 µl 10X fast digest buffer 
(Fisher Scientific), 1- 6 ng bacteriophage DNA, sterile dH2O and 1 µl fast digest Bgl II 
restriction enzymes (Fisher Scientific). Bacteriophage DNA were digested in final volume 
of 20 μl at 37°C for one hour in a mini dry bath (Fisher Scientific). In order to guarantee 
the correct incubation temperature, the dry bath had been pre-warmed for 30 min, before 
loading the samples onto 1.2 % agarose gel and electrophoretic separation run at 150 
volts for 1 hour and 15 min. The gels were visualised under UV light and images captured 
using molecular imager® Gel Doc™ XR+ imaging system.  
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3.0 RESULTS 
3.1 Isolation of ESBL producing bacteria.  
Enterobacteriaceae belongs to the normal flora in humans but may cause infections. The 
increasing level of antimicrobial resistance among clinically relevant bacteria, especially the 
increasing prevalence of ESBL producing Enterobacteriaceae is of great concern around 
the world.  
Wastewater treatment is crucial to environmental hygiene with these multi-resistant bacteria 
from various sources potentially released into the environment via effluent. Wastewater 
treatment plant effluents are considered hotspots for antibiotic resistant genes and for the 
spread of bacteria into the environment. Because these bacteria resistant to antibiotics are 
mostly enteric in origin, when excreted they can contaminate the environment and, through 
ingestion, enter new hosts. Therefore, focus of this study was put on isolating ESBL 
producing bacteria from treated wastewater, which after treatment is recycled to the public, 
potentially serving as a direct route for infections. The presence of antibiotic resistant 
bacteria also increases the potential risk of gene transfer to non-resistant hosts and so 
identifying such sources may help in finding new treatments, such as bacteriophages. 
Isolates were recovered from enriched cultures, seeded with water from the final holding 
tank of treated effluent, by culturing them on chromogenic media (Brilliance ESBL Agar, 
Oxoid) specifically designed to select ESBL-producing bacteria by the inclusion of the 
antibiotic cefpodoxime. Colonies recovered from this medium can be coloured blue or pink, 
for Escherichia isolates, green for Klebsiellia, Enterobacter, Serratia, and Citrobacter 
isolates, brown for Proteus, Morganella, and Providencia isolates, and finally colourless 
colonies for Salmonella, Acinetobacter or other isolates. From one batch sampled during 
the autumn, the majority of colonies recovered were either dark blue or colourless with one 
colony that was coloured light blue. While all six dark blue colonies were identified as 
representatives of Escherichia coli and the four colourless colonies as members of the 
genus Pseudomonas according to brilliance ESBL agar manufacturer’s manual, the light 
blue colony was not easily identified following the preliminary testing.  
While brilliance ESBL agar is specifically designed to select ESBL-producing bacteria, all 
purified and identified bacteria were further analysed for the presence of specific ESBL 
genes by PCR. The presence of CTX gene was demonstrated by a 593bp DNA amplicon 
(higher band) (Figure 10 &11) and TEM by a 445bp amplicon (lower band) (Figure 11). It 
was found that the unidentified isolate was only harbouring the CTX gene (Figure 12), E. 
coli 1 & 2 isolates showed presence of CTX and TEM genes while E. coli 4 & 5 showed 
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presence of CTX gene only (Figure 13). Only Pseudomonas 1 isolate showed the presence 
of CTX gene (Figure 13). These observations confirm, in accordance with published 
literature, that CTX is the predominant ESBL type found (Bonnet, 2004). SHV and OXA 
groups I, II and III genes were analysed but none of isolated bacteria nor control strain were 
positive for the presence of these genes.  These results confirmed that the light blue colony, 
E. coli 1, 2, 4, 5 and Pseudomonas 1 isolate were ESBL producing, which means having 
antibiotic resistance properties that can be a burden to the healthcare. Therefore, further 











Figure 12. (A) Detection of ESBL resistance determinants SHV, TEM and CTX-M using primers pairs 
BlaSHV, BlaTEM & BlaCTX, (B) Promega provided image of DNA ladder band pattern. Lane 1: 
negative control with no added DNA in the PCR reaction, lane 2: 1 kb DNA ladder, lane3: PCR 
product amplified in EwS1 DNA, lane 4: PCR product amplified in Pseudomonas 1 DNA, lane 5: PCR 
product amplified in Pseudomonas 2 DNA, lane 6: PCR product amplified in Pseudomonas 3 DNA. 
All Pseudomonas DNA were isolated from wastewater. The arrow in the figure points to the marker 
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For further identification, API 20 E and API 20 NE tests were used for identification of 
bacteria belonging to genus Enterobacteriaceae and non-fastidious, non-enteric gram-
negative rods, respectively. Bacterial identification was performed using the BIomerieux 
database and it showed that all six strains of E. coli gave 99% similarity with E. coli, 
Pseudomonas gave 97% similarity with all 4 Pseudomonas strains isolated while the light 
blue colony gave 67% similarity with Ewingella americana reference (Table 4). 
  
  1     2       3     4      5      6       7     8     9 
CTX-M (593 bp) 
TEM (445 bp) 
750 bp 
500 bp 
Figure 13. Detection of ESBL resistance determinants SHV, TEM and CTX-M using primers BlaSHV, 
BlaTEM & BlaCTX. Lane 1: positive control using DNA from EwS1 ; lane 2: 1 kb DNA Ladder, 
positions of 500 bp and 750 bp bands are indicated by arrows; lanes 3,4,6,7,8,9: PCR products of 
amplified E. coli 1-6 DNA; Lane 5: PCR product of amplified Pseudomonas 4 DNA. The arrow in the 
figure points to the marker DNA, not the space where the expected determinant would be.  
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Table 4. Summary table of isolated strains identification by selective media and characterization by 
biochemical test, sequence analysis and multiplex PCR analysis. 
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E. coli E. coli N/A E. coli CTX (593 bp) 
TEM (445 bp) 
7 Dark 
Blue 
E. coli E. coli N/A E. coli CTX (593 bp) 
TEM (445 bp) 
8 Dark 
Blue 
E. coli E. coli N/A E. coli 
 

















In a bid to identify the unknown strain, sequence analysis of the 16S rRNA gene was 
performed. The nucleotide blast analysis of the DNA sequences confirmed the identification 
of E. coli and Pseudomonas strains. However, the sequence of the unknown strain showed 
99% similarity for Ewingella, Klebsiella and Hafnia (Table 4). This result suggested that this 
bacterium is a novel one, because different colour on the chromogenic medium and the API 
test showed no similarity to Klebsiella or Hafnia, while the low similarity with Ewingella in 
the API test could not be definitive.  
The novel bacterium was sub-cultured onto LB agar plates, incubated at 30°C and found 
growing as large irregular or small regular colonies, and these were thus given the 
Isolation of ESBL producing bacteria. 
Page 46 of 137 
 
designation EwS1 for the small colony isolate and EwB2 for the large colony isolate. In an 
attempt to identify the colonies further, each isolate was subjected to physiological, and 
biochemical tests and to whole genome sequencing. 
3.2.1 Physiological characterisation of isolates EwS1 and EwB2 
The physiological characteristics of the isolates EwS1 and EwB2 were further characterised 
using Biolog, Microbial Identification System, which enables identification of aerobic gram-
negative and gram-positive bacteria in the same test panel. The strips were inoculated with 
samples of an overnight culture of the test and control (K. pneumoniae ATCC 13883) strains 
and growth was recorded after 24 and 48 hr (Figures 14 and 15). The isolates used a wide 
range of carbohydrates as carbon sources except for α-D-glucose, D-fucose, and D-
turanose (Figure 14a). Strangely, the isolates catabolise pectin, D-cellobiose, and D-
galacturonic acid but not starch. A wide range of alcohol carbohydrates was found to be 
metabolised by the EwS1 and EwB2 isolates. This included salicin, which is an alcoholic β-
glucoside found in the bark of some plants (willow) (Figure 14b). The isolates did appear to 
catabolise plant metabolites in preference to animal ones, with a lack of growth on myo-
inositol (a cell signal transducer in mammalian cells) and γ-aminobutyric acid (the chief 
inhibitory neurotransmitter in mammalian cells). 
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Figure 14. The physiological characteristics of the isolates EwS1 and EwB2 characterised using 
Biolog test strips. (A) and (B) show utilisation of carbon sources by the isolates after 48 hr incubation. 
the bars represent a positive reaction, while no bars indicate a negative reaction for the different tests 
in the panel. The figure is arbitrary denoting full growth compared to a standard and no growth 
compared to a standard. 
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.  
Both isolates grew well at pH6 and sodium chloride concentrations of 1 and 4%, but not at 
a pH of 5 or a sodium chloride concentration of 8% (Figure 15). Intestinal bacteria can cause 
aromatization of quinic acid (Cotran et al., 1960), while other intestinal bacteria can ferment 
mucic acid (Stemfield and Saunders, 1938). The isolates did not utilise mucic or quinic acid 
(Figure 15), suggesting that they might not function as intestinal bacteria. Butyric acid is a 
biologically active compound in humans and other animals, acting as an inhibitor of histone 
deacetylase or an energy metabolite to produce ATP, and a G protein-coupled receptor, 
while β-hydroxy-butyric acid is often excreted in urine. The isolates did not metabolise α-
hydroxy-butyric acid, β-hydroxy-butyric acid, or α-keto-butyric acid (Figure 15).    
 
 
Figure 15. The physiological characteristics of the isolates EwS1 and EwB2.These assays were part 
of the 94 biochemical tests done using Biolog panel. This figure shows the data for salinity, pH, 
antibiotic resistance, and utilisation of acids by the isolates after 48 hr incubation. Positive reactions 
are denoted by the presence of bars. 
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3.2.2 Temperature requirements for growth of isolates EwS1 and 
EwB2 
The growth temperature requirements of isolates EwS1 and EwB2 were determined at a 
range of temperatures from 5 to 37°C. The optimum growth for both isolates occurred at 
25°C after 10 hr incubation (Figure 16).  No growth was detected at 37°C. The exponential 
phase of growth at temperatures from 20°C to 32°C ended within 8 hr of incubation, 
whereas at 15°C it took significantly longer. However, these bacteria were capable of growth 
at 0°C to 7°C. Given that the optimal growth occurred between 20°C and 30°C, such 
bacteria could be classified as mesophiles. Although no growth was detected at 
temperatures of 37°C and above, the bacteria were not killed at these temperatures. 
Samples taken from cultures incubated at 37°C for 24 hr exhibited growth if the temperature 
was lowered to 30°C.  
 
 
Figure 16. Histogram showing the effect of temperature on growth of EwS1 and EwB2 monitored by 
OD600. the isolates were grown at different temperatures from 5-37°C for 10 hr and optical density 
was measured. The error bars represent the standard deviation.  
3.2.3 Antimicrobial susceptibility of isolates EwS1 and EwB2 
The SHV, TEM, CTX-M and OXA genes on chromosomal DNA have already been tested, 
as described above, and shown in Figure 12 and 13. Next, plasmid DNA was isolated and 
tested for these determinants. Analyses revealed that both isolates contained a single 
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and CTX-M determinants from chromosomal and plasmid DNA (Figure 17) the SHV specific 
amplicon appears as a band of 739 bp, the CTX-M as a 593 bp fragment and TEM as a 445 
bp fragment. Both isolates showed the presence of CTX-M in chromosomal and plasmid 
DNA, while the TEM determinant was present in plasmid DNA (Figure 17).   
         
Figure 17. An example image of agarose gel electrophoresis of PCR products obtained using primers 
pairs BlaSHV, BlaTEM & BlaCTX. Lane 1: PCR product amplified in EwS1 chromosomal DNA, lane 
2: PCR product amplified in EwS1 plasmid DNA, lane 3: 1 kb DNA ladder. lane 4: PCR product in 
amplified EwB2 chromosomal DNA, lane 5: PCR product amplified in EwB2 plasmid DNA. 
The initial evidence for the presence of other antibiotic resistance determinants in isolates 
EwS1 and EwB2 was provided by the results from the Biolog strip test, where both isolates 
grew in the presence of fusidic acid, troleandomycin, rifamycin, lincomycin, vancomycin and 
aztreonam (Figure 15).  
Next, antimicrobial susceptibility disc diffusion tests were performed for 13 antibiotics. Both 
isolates demonstrated a broader spectrum of antibiotic resistance in comparison to the 
control. The isolates showed resistance to 5 antibiotics: amoxicillin, cefuroxime, cefotaxime, 
gentamicin, and piperacilin-tazobactam but not to meropenem, ertapenem, ceftazidime, 
ciproflaxin (Table 5).  
 
CTX-M (593 bp) 
TEM (445 bp) 
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Table 5. Antibiotic sensitivity of isolates EwS1 and EwB2. The diameter is the length of the zone of 
inhibition. the values were compared with the minimum and maximum values with in BSAC 
guidelines to determine the resistance or sensitivity to antibiotics. N=3  








Amoxicillin (10 μg/ml) R - R - S 18 
Amoxicillin- clavulanic acid (30 μg/ml) S 22 S 22 S 34 
Meropenem (10 μg/ml) S 24 S 26 S 24 
Cefotaxime (30 μg/ml) R - R - S 6 
Ertapenem (10 μg/ml) S 28 S 26 S 22 
Ceftazidime (10 μg/ml) S 6 S 6 S 4 
Cefepime (30 μg/ml) S 28 S 24 S 32 
Tigecycline (15 μg/ml) S 20 S 20 S 24 
Amikacin (30 μg/ml) S 4 S 4 S 4 
Gentamicin (10 μg/ml) R - R - R  
Ciproflaxcin (1 μg/ml) S 22 S 24 S 30 
Piperacilin-tazobactam (75/10 μg/ml) R - R - R  
Cefuroxime (30 μg/ml) R - R - S 28 
• S – Sensitive  
• R – Resistant 
 
2.4 Molecular identification of isolates EwS1 and EwB2 
In order to clarify the identity of isolates EwS1 and EwB2 the 16S rRNA gene was PCR 
amplified and sequenced. The two sequences were identical, consisting of 1540 nucleotides 
with a base composition of A: 25.5%, C: 22.3%, G: 31.4% and T: 20.6%. Blast similarity 
searches (Table 6) identified some close matches of these sequences with those from 
uncertain species Hafnia sp strain 270 (AM403659) at 99.73%, Serratia sp HC3-9 
(JF312979) at 98.82, and Aranicola sp. NP34 (EU196321) at 100% sequence similarity. 
These matches are closely followed with sequences from recognised species:  Rahnella 
inusitata OX0101 (MG576035) at 98.61% similarity, Hafnia alvei CBA7135 (CP021971) at 
98.25% similarity; and Ewingella americans CIP81.94 (NR104925) at 98.18% similarity. 
Interestingly, the closest matches for the 16S rRNA sequences from the EwS1 and EwB2 
came from Enterobacterales strains isolated from the Artic or Antarctic:  Aranicola sp. NP34 
was isolated from a cold saline (7.5% salt) sulfidic spring in the Canadian high Arctic, 
Serratia sp HC3-9 was isolated from artic cyanobacterial mats and Hafnia sp 270 was 
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Table 6. Molecular identification of isolates EwS1 and EwB2 by blast similarity searches for 16S 
rRNA gene.  










*Hafnia sp strain 270 99.73 97 0.0 AM403659 
*Serratia sp HC3-9 98.82 99 0.0 JF312979 
Rahnella sp. ERMR1:05 98.64 100 0.0 CP019062 
 Hafnia alvei CBA7135 98.25 100 0.0 CP021971 
 Ewingella americans 
CIP81.94 
98.18 99 0.0 NR104925 
 *Aranicola sp. NP34 100.0 94 0.0 EU196321 
 Serratia grimesli BXF1 97.92 100 0.0 LT883155 
 Rahnella inusitata OX0101 98.61 97 0.0 MG576035 
• (*) strains isolated from the Artic or Antarctic. 
The 16S rRNA gene sequences from 46 taxa representing members of the 
Enterobacterales were aligned with those from the EwS1 and EwB2 isolates and their 
closest similarity matches, along with two outgroup of Vibrio sp to generate a matrix of 53 
taxa. Parsimony analysis of this matrix was performed using random sequence addition 
with 10 replications and tree-bisection-reconnection (TBR) algorithm for branch swapping 
(Swofford, 2003). This generated 702 most parsimonious trees of 927 steps with a CI = 
0.424, RI = 0.739, RC = 0.321 and HI = 0.566 and based on 221 parsimony-informative 
sites. In this analysis 5 other tree islands existed, ranging from 934 to 942 steps. Bootstrap 
analysis produced a consensus tree (data not shown) with little internal support within the 
Enterobacterales, except for a clade of the EwS1 and EwB2 isolates with Hafnia sp strain 
270, Serratia sp HC3-9 and Aranicola sp. NP34 (100% support), and a clade of these 
sequences with those from Rahnella species (89% support). Maximum likelihood estimates 
of the parsimony trees revealed that different likelihood In (L) values existed for some trees 
within the population, ranging from - 6932.139 to -6940.375. A maximum likelihood analysis 
was performed on the 53 taxa data matrix using the model GTR (Swofford,2003) and 
estimated values for nucleotide frequencies as well as for the frequency of 
invariable/variable sites, together with a non-parametric bootstrap analysis. The resultant 
tree had a -In (L) -6924.159604 (Figure 18) and showed a low level of support for a split 
between the members of the Yersiniaceae and the rest of the Enterobacteriaceae (75% 
support), with the EwS1/EwB2 sequences forming a well-supported clade with those from 
Hafnia sp strain 270, Serratia sp HC3-9 and Aranicola sp. NP34 (99% support) within the 
Yersiniaceae.  
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Figure 18. Consensus maximum likelihood tree showing the relationships between derived 16S rRNA 
gene sequences and those of two outgroup species of Vibrio, where In(L) = -6924.159604, Pinv = 
0.696826, α = 0.478734. Bootstrap [DG1] values above 50% are shown above the branches. the 
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Figure 19. Maximum parsimony analysis of 16S rRNA gene sequences and those of two outgroup 
species of Vibrio. Strict consensus tree (CI = 0.549, RI= 0.744, RC = 0.408, and HI = 0.451) of 574 
steps (PIC = 187). Representing 88 trees from 3 tree islands all of 574 steps, showing the 
relationship.  Yersiniacaea. 
A data matrix containing 32 OTUs representatives of the family Yersiniaceae, with 2 species 
of Vibrio as outgroup taxa, was constructed for 16S rRNA gene sequences. Maximum 
parsimony analysis of this data set produced 88 trees of 574 steps using 187 parsimony 
informative sites. Figure 19 shows that the strict consensus of these trees with bootstrap 
values for nodes. This analysis shows the ESBL isolates EwS1 and EwB2 formed a strongly 
supported clade (96%) with sequences from isolates recovered from cold environments 
(Hafnia sp. NJ-71 and Serratia sp. 6rig), which is separate from all other genera.  
ESBL 
Isolates 
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The relationship between taxonomic identification and sequence similarity for the 16S rRNA 
gene has been discussed by McDonald et al (2012) and Siegwald et al (2017): They 
recommended that sequence reads should be grouped into 3 bins: those showing 90-97% 
similarity that approximates to the family level; >97-99% similarity for genus level identity; 
and >99% similarity for species level identity. Table 7 shows the 16S rRNA sequence 
similarity matches for the isolates EwS1 and EwB2 with members of the genus Rahnella 
and Ewingella. Using the Ion Reporter rubrics, the isolates EwS1 and EwB2 belong to the 
genus Rahnella, as should Ewingella americana.  
Identification according to 16S rRNA sequence similariity can be misleading, especially 
when dealing with closely related species. Brady et al (2013) adopted a multi-locus 
sequence approach to evaluate the significance of the genus Enterobacter concluding that 
the relationship inferred using 16S rRNA gene sequences was incompatible with that 
produced using four protein-coding essential genes. This conclusion was supported by Sato 
and Miyazaki (2017) who re-evaluated the cohesiveness of the genus using 194 genes from 
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Table 7. Percentage sequence similarity for 16S rRNA gene sequences for Rahnella and Ewingella species 
 EwS1 EwB2 
Rahnella 
chamberiensis        
Rahnella 
badensis            
Rahnella 




inusitata           
Rahnella 
woolbedingensis        
Rahnella  
bruchi            
Rahnella  




 100 100 98.5 98.8 97.7 97.6 98.7 97.9 97.9 96.9 98.1 
EwB2 
  100 98.5 98.8 97.7 97.6 98.7 97.9 97.9 96.9 98.1 
Rahnella 
chamberiensis          100 99.1 98 97.8 99.7 98.3 98.3 97.8 98.1 
Rahnella 
badensis    100 98.2 98.1 99.2 98.4 98.4 98 98.2 
Rahnella 
variigena             100 99.6 98.1 99.5 99.4 100 98.2 
Rahnella  
victoriana      100 98 99.1 99.1 99.6 98 
Rahnella 
inusitata                 100 98.3 98.3 97.9 98 
Rahnella 
woolbedingensis               100 99.9 99.4 97.1 
Rahnella 
bruchi                    100 99.3 97.1 
Rahnella 
aquatilis                     100 98.2 
Ewingella  
americana           100 
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3.2.5 Multi-loci phylogeny of house-keeping genes 
Phylogenies based on ribosomal RNA small sub-unit gene sequences do not distinguish 
between closely related species sufficiently, while the API20E or VITEK 2 identification kits 
do not identity gram-negative, fermentative, oxidase-negative isolates well, often 
suggesting Ewingella americana or Pantoea sp. as possible identities. Multi-locus 
sequencing analysis or typing (Maiden et al., 1998) is a technique designed to molecularly 
classify closely related species, where sections of house-keeping genes are combined and 
analysed phylogenetically. This approach has been used successfully to classify closely 
related species of fungi and bacteria, including the Enterobacteriaceae where the genes 
fusA (translation elongation factor G), pyrG (CTP synthase), rplB (50S ribosome protein 
L2), rpoB (β subunit RNA polymerase) and sucA (2-oxoglutarate dehydrogenase E1) were 
used to type Pantoea, Rouxiella and Enterobacter species (Delétoile et al., 2009; Le Flèche-
Matéos et al., 2015, 2017; Paauw et al., 2008). Therefore, this method was applied in this 
study. 
Sequences of the aforementioned five genes were obtained for 47 taxa, ensuring that they 
had the same origin, and aligned to those from isolates EwS1 and EwB2 to generate a 49 
taxa matrix, with species of Proteus included as outgroup taxa. Matrices for each gene were 
constructed separately to test that the phylogenies produced were congruent. All genes 
except for fusA produced congruent trees (data not shown) so fusA sequences were 
removed from the matrix, which is the standard approach in phylogenetic analyses. 
Maximum likelihood analysis of the resulting matrix using the TN93 model and non-
parametric bootstrap analysis produced a strongly supported tree (Figure 20) of In (L) = -
86239.2, Ts/ts ratio = 5.384303, alpha = 0.871231 and P-inv = 0.517210. The matrix 
comprised 9394 sites, from which 59.52% were monomorphic, and from which the analysis 
identified 3303 separate patterns. The EwS1 and EwB2 sequences form a strongly 
supported clade (100% bootstrap) within a larger clade comprising sequences from 
Rahnella and Rouxiella species that is also strongly supported (100% bootstrap) and which 
forms a sister clade with sequences from species of Yersina and Serratia - at 94% bootstrap 
support. This group is separate from other members of the Enterobacteriaceae, and it is 
consistent with the results presented for the genome comparison study (Chapter 3, Figure 
21, 22, and 23).  
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Figure 20. Four gene phylogeny (genes pyrG, rplB, rpoB and sucA) showing the relationship between 
the ESBL isolates EwS1 and EwB2 (boxed) within the Yersiniaceae. Maximum likelihood analysis of 
9394 nuelotide sites using model TN93 with 4 rate classes generated 3303 patterns, 59.52% of which 
were monomorphic.  Using estimated values of Ti/Tv ratio (5.384303), alpha (0.871231) and P-inv 
(0.517210, maximal likelihood analysis using nearest neighbor interachange (NNI) produced a tree 
of In(L) = -86239.2. The figure shows a majority consensus cladogram of a bootstrap analysis with 
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The isolates EwS1 and EwB2 form a strongly supported clade with members of the genus 
Rahnella. The question remains whether these isolates are members of the Ewingella, 
Rahnella or whether they represent a new genus. To answer this question, the isolates were 
characterised for the key characteristics of the genera Rahnella, Rouxiella, Ewingella, 
Serratia, Hafnia and Klebsiella using biochemical test described by Bergey and Holt, 2000. 
Table 8 summarises these key characteristics.  
Table 8. The key characteristics of the isolates EwS1 and EwB2. compared to Hafnia, Ewingella, 
Serratia, Rouxiella, Klebsiella and Rahnella. 
Characteristics EwS1/EwB2 Ewingella Serratia Rouxiella Hafnia Klebsiella Rahnella 
Growth at 4°C + - -  - - + 
Growth at 37°C - + + + + + + 
Growth at 40°C - -      
Growth at 8% NaCl - +   -   
Mobility + + + -  - ± 
Simon’s Citrate - + + +  + + 
Voges-Proskauer 
reaction 
- - + + + + + 
Methyl-Red + + -  V - + 
Urea hydrolysis - - + -  + - 
Sucrose + - + - -  + 
D-glucose, gas 
production 
+ -  -   + 
D-Sorbitol + - + - -   
Glycerol + - + -   - * 
L-Arabinose + - - +   + 
Myo-Inositol - - + +  + - 
Melibiose + - - + -   
Raffinose + - - - -  + 
Cellobiose + - - - -  + 
Maltose + - + -   + 
D-Mannitol + + + + + + + 
L-Rhamnose + - - +   + 
H2S production - - -    - 
Lysine decarboxylase - - + V + + - 
Ornithine 
decarboxylase 
- - +  +  - 
Gelatin hydrolysis - - + -   - 
Chitin + +     + 
Lactose + - - - -  + 
Salicin +  +  -  + 
Trehalose +  + -    
D-Arabitol +  V -   - 
different  14/32 12/32 12/32 11/32 7/32 4/32 
similar  18/32 20/32 20/32 21/32 25/32 28/32 
V- Variable 
EwS1 and EwB2 have a different profile to those of all the other genera. Specifically, the 
isolates are capable of growth at low temperature and cannot utilise citrate or possess lysine 
and ornithine decarboxylases. They have the ability to utilise cellobiose, pectin and chitin, 
which might be linked to the degradation of plant and insect material. Out of 32 
biochemical/physiological tests, the two isolates show the greatest similarity to the genus 
Rahnella (Table 8).  
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Species belonging to the genus Rahnella are facultative anaerobes, nitrogen fixers that can 
utilise citrate, they can ferment a range of sugars including salicin, and do not possess 
lysine and ornithine decarboxylases. They do exhibit mobility but only at temperatures of 
25ºC. They inhabit fresh water, soil, have been isolated from the guts of snails and beetles 
(Brenner et al., 1998; Park et al., 2007), and are recognised as being associated with plant 
roots. Rahnella aquatilis is known to cause disease in humans, specifically bacteraemia 
(from renal infection), sepsis, respiratory and urinary tract infections. It has also been shown 
to be involved in meat spoilage (Godziszewska et al., 2017). Its genome size ranges from 
4.8 to 5.4 Mbp with a G-C content of 52.1% (Martinez, 2010). Furthermore, it can grow at 
temperatures from 4 to 10ºC (Tash, 2005) and a temperature sensitive isolate was 
recovered that could not grow on MacConkey or Blood Agar at 37ºC (Domann et al., 2003). 
The differences between the isolates EwS1 and EwB2 and members of Rahnella are few 
but significant: the inability to utilise citrate but to use glycerol and the lack of the Voges-
Proskauer reaction.  
3.2.6 Genome comparison 
In order to obtain even greater understanding of these ESBL-producing bacteria and their 
taxonomic relationships, a step-by-step characterisation was done. The 16S rRNA gene 
was sequenced and analysed first, then a 4 gene analysis of putative genes, and now full 
genome sequencing. The genome size of isolates EwS1 and EwB2 were 52 and 51 Mbp, 
respectively with a GC content of 52.27% (53.37% and 53.38% respectively for gene coding 
regions) and base frequencies of 23.75% and 23.77% A, 25.93% and 26.01% C, 26.33% 
and 26.25% G and 23.97% and 23.95% T for EwS1 and EwB2 respectively (23.35% A, 
25.86% C, 27.5% G and 23.27% T for gene coding regions of EwS1, and 23.33% A, 25.87% 
C, 27.5% G and 23.28% T for gene coding regions for isolate EwB2). Each isolate carried 
a plasmid of 10 kbp.  
A comparison of genome sequences in FASTA format, with the One Codex genome library 
(https://app.onecodex.com/) was made to identify their taxonomic origins. The library 
comprises 53,193 bacterial, 27,020 viral, 1,724 fungal, 1,756 archaeal, and 168 protozoan 
genomes (83,863 including host). This analysis recognised that the genome sequence of 
isolates EwS1 and EwB2 represented a low-complexity sample of Ewingella americana 
(likely strain: Ewingella americana ATCC 33852). In the sample EwS1, 1.15% of reads 
(n=1) were specific to Ewingella americana. Overall, 72.41% of 87 reads were classified. 
An additional 1.15% of reads were classified but are non-specific or host reads. Similarly, 
In the sample EwB2, 23.46% of reads (n=19) were specific to Ewingella americana. Overall, 
77.78% of 81 reads were classified. Histograms showing the proportions of read counts for 
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the genome matches at the family and genus levels are shown in Figure 21. Both isolates 
have genomes that match ones found within the Enterobacterales at the 92% level for 
isolate EwS1 and 87% for isolate EwB2 (Figure 21a).  
 
Figure 21. Histogram showing the proportion of read counts for the genome matches at the family 
and genus levels. (A) The figure shows at family level both isolates largely (87-92%) belonging to 
the Enterobacterales family. (B) the figure shows that at genera level, the most identified genera 
belonging to these isolates are Yersiniaceae (68-74%) and Enterobacteriaceae (16-17%).  
At the genus level, both isolates have genome matches within the Yersiniaceae at 74% for 
isolate EwS1 and 68% for isolate EwB2, with a smaller proportion for Enterobacteriaceae 
at 16% for isolate EwS1 and 17% for EwB2. The mixed nature of these genomes suggests 
that they are novel, not being wholly represented by a single genus, as is the case for 
taxonomically defined species. Figures 22 and 23 shows the genome comparisons between 
the EwS1 and EwB2 with those form the One Codex library at the levels of genus and 
species, respectively. Unlike defined species, such as Ewingella americana ATCC 33852 
(NZ JMPJ01000001, bioproject: PRJNA224116) and Rahnella aquatilis ATCC 33071 (NC 
016818, bioProject: PRJNA224116) that have 100% of their genome sequence reads 
matching their designated library counterpart, the genome reads of isolates EwS1 and 
EwB2 display a range of matches. The principal sequence reads from the isolates matched 
those from Ewingella americana (46% for EwS1 and 37% for EwB2) and Rahnella victoriana 
(15% for EwS1 and 12% for EwB2). The analysis identifies that the isolates are made up of 
regions matching those from genera outside the Enterobacterales, representing 18% for 
EwS1 and 25% for EwB2 (Figure 22). Although the majority of reads matched those from 
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genera\species within the gamma-proteobacteria, small proportion were linked with 
genera/species from an alpha-proteobacteria and gram-positive bacteria, such as 
Streptomyces species (Figure 23).    
 
Figure 22. Histogram of the genome reads of ESBL S1 isolate (EwS1) and ESBL B2 isolate (EwB2) 
for genera level. The bars denoting Ewingella americana ATCC 33852 and Rahnella aquatilis ATCC 
33071 shows 100% match of their genome reads to their assigned library reads. For isolates EwS1 
and EwB2, their genome reads match 33-40% for Ewingella, 18-25% for any of the listed other 
bacteria, 11-16% for Rahnella, 12-13% for Serattia, 5.5-11% for Yersinia, 5.5-7% for Enterobacter 
and 1.8% for no genus.  
 
Figure 23. Histogram of the genome reads of ESBL S1 isolate (EwS1) and ESBL B2 isolate (EwB2) 
for species level. Ewingella americana ATCC 33852 and Rahnella aquatilis ATCC 33071 Bars shows 
100% genome reads to match their corresponding species. while isolates Ews1 and EwB2, their 
genome reads match 37-46% for Ewingella americana, 25-43% for other bacteria listed, 12-15% for 
Rahnella victoriana, 7.8-8.3% for Serratia sp. leaf51, isolate EwS1 showed a 6.3% genome read to 
Rahnella aquatilis.  
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This cluster-based structure of a microbial genome is consistent with the Core Genome 
Hypothesis (CGH) definition of a bacterial species, where horizontal gene transfer has been 
important (Lan and Reeves,1996).  The CGH predicts that a sub-set of genes, the core, is 
present in all members of a species that give the species its characteristics. These core 
genes display a neutral rate of evolution, whereas auxiliary genes will experience a variety 
of selective pressures (Riley and Lizotte-Waniewski, 2009).  
Comparative genome analyses of six Escherichia coli strains, including the genome of 
Shigella flexneri, demonstrated that these strains had genomes with a highly conserved 
backbone of 3000 genes, punctuated by many ‘sequence islands’ that were strain-specific 
(Mau et al., 2006). Using the progressive alignment implemented in Mauve based on HOXD 
scoring (Darling et al., 2004, Bertelli et al., 2017), an alignment was constructed for the 
genomes of ESBL isolate EwB2 and Rahnella victoriana BRK18a (Acc. no. 
MAEN01000001) using the sequences from Ewingella americana NCTC12157 (Acc. no. 
UGGO01000001) as the reference (Figure 24). Despite the great similarity between the 16S 
rRNA gene sequences from these organisms, the genomes do not share a common 
conserved structural backbone. Instead, there exists a series of smaller homologous 
regions that appear to have undergone significant rearrangements. Ewingella americana 
had 79 local colinear blocks (LCB) between the two other genomes, while Rahnella 
victoriana had 83 and EwB2 had 87. The weight of these blocks (sum of the matches within 
the block) is a measure of confidence that the LCB is a true genome rearrangement and 
the cut off for the minimum weight can be increased to identify rearrangements that are 
likely to exist or decreased to detect smaller genome rearrangements. The Mauve default 
minimum value to construct a co-linear block (3 times the minimum similarity match size) 
was used to construct the blocks in the three-genome comparison. This number of colinear 
blocks determined from this analysis was consistent with numbers detected between the 
different genomes of Yersinia (Chen et al., 2010).  
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Figure 24. Three genome comparison of Ewingella americana, Rahnella victoriana and ESBL isolate 
EwB2. The reference sequences were from Ewingella americana NCTC12157 (Acc. no. 
UGGO01000001) showing that Rahnella victoriana and isolate EwB2 had similar regions in their 
conserved backbone that has undergone rearrangement.  the LCBs identified by a letter are some 
blocks present in all three genomes, whereas those identified by numbers are those absent or 
present in two genomes. the LCBs shown below the line are inverted blocks.  
The LCBs of the alignment (Figure 24) are either present in all three genomes, present in 
two of the genomes or absent from two genomes. The common LCBs have undergone 
rearrangements, including location changes, inversions, and deletions, but contain common 
coding sequences (CDs) (Figure 25). Other blocks may not be present in all genomes and 
contain large deletions. Figure 26 shows an enlargement of region 5, which contains some 
similarity between the genomes but is dominated by a large deletion of approximately 55 
kbp in Ewingella americana and Rahnella victoriana. The CDs present in this region for 
EwB2 include the virulence factor slrB, a beta-lactamase coding region bla, and tellurium 
resistance coding protein region, terA as well as features associated with a conjugative 
plasmid (mobC) and a transposon (Tn2501). These features suggest that the genes in this 
region may have been introduced by horizontal transfer. This pattern was repeated in other 
regions specific to genome of EwB2. This genome contained approximately 1000 kbp that 
was specific to this isolate and included CDs specific to iron acquisition, virulence factors, 
antibiotic resistance, metal resistance and secretion (Table 9) along with additional 
transposons Tn21, IS1111A, IS3A and IS4.   
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Figure 25. Region A containing CDs common to all three genomes. CDs include: secD (protein 
translocase subunit), tig (trigger factor), mntA (manganese binding lipoprotein), secF (protein 
translocase subunit), clpP (ATP-dependent CLP protease, proteolytic subunit), acrB (acriflavine 
resistance protein B), yhjA (cytochrome peroxidase), clpX (ATP-dependent CLP protease ATP 
binding subunit),  acrA (acriflavine resistance protein A), yhjI (lipoprotein), lon (LON protease), 
acrR (HTH-type transcriptional regulator),  ribD (riboflavin biosynthesis protein), ppiD (peptidyl-prolyl 
cis-trans isomerase), kefA (Potasium efflux system kefA), ribH ( 6, 7 – dimethyl-8-ribityllumazine 
synthase), queC (7-cyano-7deazaguanine synthase), thiH (thiamine monophosphate kinase), cof 
(HMP-PP phosphatase), dxs (deoxy – D-xylulose-5-phosphate synthase), cysM (cysteine synthase),  
ispA (farnesyl diphosphate synthase), mdlA (multidrug resistance-like ATP binding subunit), thiI 
(tRNA sulfurtransferase), mdlB (multidrug resistance-like ATP binding protein), panE (2-
dehydropantoate 2-reductase), amtB (Ammonia channel), yajR (inner membrane transport protein), 
tesB (acyl-Co thioesterase), cyoE (protoheme IX farnesyltransferase), ybaY (lipoprotein), cyoD 
(cytochrome o ubiquinol oxidase protein), yicO (putative permease), cyoC (cytochrome o ubiquinol 
oxidase subunit 3), ade (adenine deaminase), cyoB (ubiquinol oxidase subunit 1), oxyR (hydrogen 
peroxide – inducible genes activator), cyoA (ubiquinol oxidase subunit 2), fhuC (metal transport 
system ATP binding protein CPn), ampG (Protein AMP G), mntC (manganese transport system 
membrane protein). Although Region 5 is a conserved block (located at different positions in the 
three genomes), deleted sections exist for each species where a gene is missing. For example, in 
the isolate EwB2 genome there is a deletion for the yhJ A gene, which is present in the other 
genomes. Deleted regions are identified as gaps in the alignment. 
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Figure 26. Region V containing CDs specific to ESBL isolate EWB2. The CDs include: ydfM 
(uncharacterized transporter), terA (tellurium resistance protein),   yodB (cytochrome b561 homolog),  
VEP (virulence effector protein), ydgK (MFS-type transporter), srlB (virulence protein), mccF 
(microcin C7 self-immunity protein), VF (virulence factor), mdmC (O-methyl transferase), lolD 
(lipoprotein-releasing system ATP binding protein), yqlQ (oxidoreductase), tnpR (resolvase Tn2501), 
tcp (methyl accepting chemotaxis citrate transducer), int (integrase family), lysS (lysyl- tRNA 
synthase), mobC (MOB C protein), ada (bifunctional transcription activator), yijR (HTH-type 
transcription regulator), nhoA (N-hydroxylamine O-acetyltransferase), yrhP (membrane protein), bla 
(beta-lactamase containing domain protein), gcvA (glycine cleavage system transcription activator). 
Region V is primarily a deletion in Ewingella and Rahnella. The yellow block shows a region of some 
similarity between Ewingella, Rahnella and EwB2. The bottom gene map is for EwB2. The top 
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Table 9. Iron acquisition, virulence factors, antibiotic resistance, metal resistance and secretion. 
Activity Gene Function Activity Gene Function 
Iron acquisition fbpA Fe (3+) binding periplasmic  Heavy metal terZ tellurium resistance 
 fbpB Fe (3+) transport permease  terA  
 fbpC Fe (3+) ion import  terB  
 entF enterobactin synthase  terC  
 entS enterobactin exporter  arsH arsenic resistance 
 entE Enterobactin synthase  tehB  
 entB isochorismatase Antibiotic 
resistance 
macA  
 entC isochrismate synthase    
Virulence srfB Virulence protein  mdtA Multidrug transporter. confers resistance against novobiocin and 
deoxycholate. MdtABC requires TolC for its function 
  virulence effector protein  acrD aminoglycoside efflux pump 
  virulence factor  mmr methylneomycin resistance 
 yeeJ invasion  bla Beta-lactamase CTX-M-2 
 sprA virulence protein  tcmA tetracenomycin resistance protein 
 sprB mono ADP-ribosyltransferase  bla  
 shlA hemolysin  bla TEM Beta-lactamase TAM 
 hpmB hemolysin transporter  smvA viologen resistance 
 fepA hemoglobin binding Chemotaxis trg methyl accpeting chemotaxis protein III 
 fhaB filamentous hemagglutin  tcp methyl accepting chemotaxis citrate transducer 
 fhaC filamentous hemagglutin transporter 
protein 
Secretion clp VI VI protein 
 hrtE OMP usher protein  icmF type VI secretion protein 
 fimB chaperone protein  datL typw IV/VI secretion system 
 ipfA long polar fimbria protein A  impA type VI secretion associated protein 
 ipfB chaperone  vgr type vi secretion system 
 ipfC outer membrane protein    
 fimG   pqiA paraquate-inducible protein A 
 ydeR fimbrial subunit  pqiB paraquate-inducible protein B 
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The presence of genomic islands (GEIs) can be taken as evidence for horizontal gene 
transfer in the evolution of bacteria (Juhas et al., 2009). These elements are defined as 
discrete DNA segments between closely related strains, to which some past or present 
mobility can be attributed. As a result of selective pressure, these elements can code for a 
variety of functions important in the adaptation of the organism to the environment, and 
include complex traits such as pathogenicity, symbiosis, sugar and aromatic compound 
metabolism, mercury resistance and siderophore synthesis. GEIs can be detected using a 
number of models: the IslandPath-DIMOB model determines the presence of GEIs based 
on nucleotide bias and the presence of mobility genes (Hsiao et al., 2003), whereas the 
SIGI-HMM model uses codon usage bias combined with a hidden Markov model (Waack 
et al., 2006) and the IslandPick model which uses a comparative genomics approach to 
detection (Langille et al., 2008). IslandViewer 4 (Bertelli et al., 2017) implements all of these 
models, including Islander (Hudson et al., 2015), which uses a database of tRNA and 
tmRNA genes as integration sites for GEIs. Genome comparisons of EwB2 and EwS1 with 
reference sequences from Rahnella aquatilis HX2 identified 14 common islands based on 
SIGI-HMM and IslandPath-DIMOB models (Figure 27). 
 
 
Figure 27. Circular genome maps of EwB2 and EwS1 showing the location of 14 Genomic Islands 
based on the integrated IslandPath-DIMOB (red), and SIGI-HMM (blue) models constructed using 
reference genome sequence from Rahnella aquatilis HX2. The grey areas denote gaps or missing 
sequences between the target and reference sequences. 
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Figure 28. Genetic structure of GEI Region V for (a) isolate EwB2 and (B) isolate EwS1. The Blue 
block represents the SIGI-HMM determined block, while the orange blocks were determined by the 
IslandPick model. The genes are present as pink-flesh or green blocks, representing different coding 
directions. Those genes readily identified by Blast searches are labelled. 
An additional 11 potential regions were identified that were located at different sites. The 
architectures of the core putative islands are identical (Figure 28) between isolates EwB2 
and EwS1, whereas the potential strain specific regions contain blocks that are identical but 
integrated at different sites (Figure 29). Interestingly, many of these blocks were adjacent 
to or included deleted regions, like that depicted in Region A (Figure 29). Regions that may 
represent GEIs are present in genomic regions of EwB2 and EwS1 that are absent from the 
genome of Rahnella aquatilis HX2. Many of these islands have virulence genes or antibiotic 
resistance genes associated with them, although no pathogenic GEIs were identified in 
these analyses.    
 
Figure 29. Genetic structure of GEI Region A for (a) isolate EwB2 and (b) isolate EwS1. The Blue 
block represents the SIGI-HMM determined block, while the orange blocks were determined by the 
IslandPick model. The genes are present as pink-flesh or green blocks, representing different coding 
directions. Those genes readily identified by Blast searches are labelled. Deletions of regions from 
the comparison genome of Rahnella aquatilis HX2 are shown as gray areas. 
A genome alignment between the sequences from isolates EwB2 and EwS1 was 
constructed using Mauve (Darling et al., 2004; Darling et al., 2010), allowing node 
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sequences from isolate EwS1 to be aligned to those from isolate EwB2 (Figure 30). The 
Mauve genome alignment procedure generates a global alignment of local colinear blocks 
that share sequence similarity. The algorithm finds local alignments, identifying multiple 
maximum unique matches (MUM) that it uses to create a guide tree using the neighbor-
joining method. A sub-set of these MUMs are used as an anchor, called a local colinear 
block (LCB), a series of which are used to refine the alignment. Genome rearrangements, 
where regions may be re-ordered or inverted relative to related genomes, can be identified 
using the position of LCBs. From 87 contigs 23 LCBs were identified between the two 
genomes, with an average length of 268334.053 base pairs (and a median of 87294), with 
the longest LCB being 2854755 base pairs and the shortest 5019 bps.  
The resolution level of the alignment can be altered by weighing LCBs. The weight of the 
LCB is defined as the sum of matches in that LCB, setting the level of mismatches can 
therefore change the resolution. The weight of an LCB provides a measure of confidence 
that it is a true genome rearrangement and selecting a high minimum weight during 
alignment, identifies genome rearrangements that are very likely to exist, whereas by 
selecting a lower minimum weight, some specificity can be traded for sensitivity to smaller 
genome rearrangements. So, by raising the minimum weight value the number of lower 
matching LCBs can be reduced (Darling et al., 2004). Therefore, changing the minimum 
weights of each block to 83981 or 195952 reduced the number of LCBs from 10 (Figure 
30b) to 4 LCBs (Figure 30a), respectively. Most of the structural rearrangements within the 
genomes has taken place between nucleotides 2854755 and 4068339, with the first 
2854755 nucleotides being identical and minor rearrangements occurring between 
nucleotides 4068339 to 5109618. The number of complete coding sequences between the 
two genomes was 4623, with 106 SNPs. The LCBs within the 2854755 to 4068339 
nucleotide regions were found compositionally similar but with major structural 
rearrangements of blocks. For instance, the gene composition and order within LCB 2, 3 
and 4 are the same but in the reverse order in EwS1 (Figure 31). 
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Figure 30. Alignment of the genome of isolates EwB2 and EwS1 using Mauve. (a) a minimum weight 
of 83981 generated 10 LCBs. (B) A minimum weight of 195952 reduced this number to 4 LCBs. The 
use of a lower arbitrary weight (greater mismatches between nucleotides) identified two conserved 
regions (LCB 1 and LCB 4) between the two genomes that were positionally similar. Other conserved 
regions (LCB 2 and LCB 3) showed rearrangements. The main rearrangements took place between 
nucleotide position 2854755 to 4068339. To identify conserved sections that had undergone 
rearrangement within this region, the weight was increased (b). Increasing the stringency for 
mismatches identified a further 8 LCBs (LCB 2 to 9), the rearrangements of which are shown in the 
above diagram.    
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Figure 31. The genetic structures of LCB regions 2 (A), and 3/4 (B) for isolates EwS1 and EwB2. 
The regional LCBs were mapped using Genome Compiler version 2.2.BB and the appropriate gbk 
files. 
3.2.7 Molecular features of the EwS1 and EwB2 genomes 
The abilities of isolates EwS1 and EwB2 to degrade cellobiose, pectin, D-galacturonic acid, 
D-mannitol and D-sorbitol as well as having the genes (pqiA and pqiB) inducible by paraquat 
suggest that these organisms are adapted to interact or associate with plants in the 
environment. In support of this idea, the isolates also contain a putative limB gene coding 
for an oxygenase capable of degrading limonene, present in citrus fruit and a component 
of the herbicide Avenger, genes for Quercetin, which is a plant flavanol; and genes for the 
A 
B 
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degradation of acetophenone (putative gene yhhW), present in many plant-based foods. In 
addition to these, others putative genes exist in these isolates: licC for lichenin transport (a 
complex glucan occurring in certain species of lichens), and cycB gene for binding of 
cyclodextrin, a product of starch degradation). Nevertheless, it is unclear whether the 
isolates EwS1 and EwB2 are plant pathogens.  
To be considered a plant pathogen, the isolates should have virulence or avirulence factors 
for: (1) phytotoxin production, (2) stress survival, (3) Quorum sensing, (4) type III secretion 
system, (5) biofilm formation and (6) cell wall degrading enzymes/system (Melotto and 
Kunkel, 2013). The analyses of genomes of EwS1 and EwB2 undertaken here, revealed 
that these isolates certainly contain putative genes coding for functions that would satisfy 
four of these categories: (i) Genes coding for a variety of stress responses, including acid 
(genes asr, ibaG and hdeA), heat (genes ibpA and B, hslR), and cold (genes cspA, C, E 
and G) shocks as well as nutrient starvation (cstA, rspB, sspA and B), and cryoprotectant 
metabolite (genes yehW, X, Y, Z) are present (Table 10). (ii) Genes that share similarities 
to already characterized genes associated with chemotaxis, (iii) Genes involved in quorum 
sensing and (iv) Genes involved in biofilm formation (Table 10) are also present, including 
members of the DMT (genes rhtA, yijE, yddG, yedA) and RhtB/LysE (genes rhtB, rhtC, leuE, 
argO) families and their controlling protein Lpr. These families are involved in the export of 
amino acids, purines and other metabolites such as homoserine/homoserine lactone 
thought to play a role in quorum sensing (Zakataeva et al., 2006). The presence of these 
genes suggests that these isolates are adapted to cold environments (Chattopadhyay, 
2006). No putative genes coding for phytotoxins, such as coronatine or syringolin, were 
identified, however other genes coding for animal/human toxins and virulence factors were 
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Table 10. Molecular features of the EwS1 and EwB2 genomes, with emphasis on genes responsible for antibiotic resistance, chemotaxis and stress 
responses. 
Gene Function Gene Function Gene Function 
Chemotaxis ywr O General stress protein mda B Adriamycin 
trg Methyl-accepting chemotaxis protein III yehW, X, Y, Z glycine betaine uptake system stt H Streptothricin 
che A, B, R, Y, V, W Chemotaxis proteins yhd N General stress protein yhe I multidrug resistance ABC transporter 
qse G Quorum-sensing regulator protein G oxy R Hydrogen peroxide-inducible genes activator Bacterial interactions 
aer Aerotaxis receptor ssp A, B Stringent starvation proteins A and B caf 1A F1 capsule-anchoring protein 
tap 2, 3 Methyl-accepting chemotaxis proteins II and IV egt B Hercynine oxygenase sto A Sporulation thiol-disulfide oxidoreductase A 
tar Methyl-accepting chemotaxis protein II tau A, B, C, D Taurine import system soj_2 Sporulation initiation inhibitor protein Soj 
mot A, B Motility proteins A and B ssu A, B, C, D, E aliphatic sulfonates utilization mli C 
Membrane-bound lysozyme inhibitor of C-type 
lysozyme 
tsr Methyl-accepting chemotaxis protein I   Barstar Barstar 
ytn P putative quorum-quenching lactonase YtnP Antibiotic Resistance big R Biofilm growth-associated repressor 
Stress response acr A, B, F, Z Multidrug/aminoglycoside export proteins pga D Biofilm PGA synthesis protein PgaD 
asr Acid shock protein bcr 2 Bicyclomycin resistance protein tab A Toxin-antitoxin biofilm protein TabA 
bhs A Multiple stress resistance protein bla Beta-lactamase, CTX-M rat A Ribosome association toxin 
csp A, C, E, G Cold shock proteins drr A Daunorubicin/doxorubicin resistance licB antigenic determinant 
cst A Carbon starvation protein A bla_ToHo1 Beta-lactamase, CTX-M2  Solvent resistance 
lba G Acid stress protein bla_TEM Beta-lactamase, TEM qacA Antiseptic resistance 
ibp A, B Small heat shock protein mdt A, B, C, H, K, L, N multi-drug resistance (Chloramphenicol) srpA Solvent efflux pump 
hde A Acid stress chaperone bmr 3 Multi-drug resistance padC Phenolic acid decarboxylase 
hsl R heat shock protein emr A, B, D, E, K Multi-drug resistance aae A, B p-hydroxybenzoic acid efflux 
rsp B Starvation-sensing protein fsr Fosmidomycin resistance Thermostable enzymes 
srk A Stress response kinase mdl B, G multi-drug resistance 02691 Thermostable carboxypeptidase  
yce D Stress response protein mex A Multidrug resistance gntK Thermoresistant gluconokinase 
typA GTP-binding protein TypA/BipA mac A Macrolide export protein bglB Thermostable beta-glucosidase  
osm Y Osmotically inducible protein  mfs spectomycin/tetracycline nuc 
Thermonuclease 
yehW, X, Y, Z – glycine betaine uptake system – cryoprotection; typA - GTP-binding protein TypA/BipA – involved in cold adaptation
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Table 11. Molecular features of the EwS1 and EwB2 genomes. This includes genes that can function 
is virulence and toxicity, genes that can bacteria to stick to surfaces, genes that help bacteria in 
metabolism, iron acquisition, metal resistance, transportation. 
Gene Function Gene Function Gene Function 
Fimbriae and Pili Virulence & Toxins bfr Bacterioferritin 
yra I, H, J, K 
fimbrial proteins 
cbtA Cytoskeleton-binding toxin CbtA 
ytf E 
Iron-sulfur cluster repair 
protein 
smf 
Major fimbrial sub-unit 




parE, D Toxin ParE1, Antitoxin ParD1 
iuc C  
Aerobactin synthase 
csg A, B, C, D, 
E, G 
Curli production higA, B Antitoxin HigA1, Toxin HigB-2 aer 
Aerobactin receptor 
fik 
Flagella regulator cdiA Toxin CdiA apb C Iron-sulfur cluster carrier protein 
lpf A, B fimbrial sub-unit, chaperone cbeA 
Cytoskeleton bundling-
enhancing protein efe U, O Ferrous uptake system 
fim D 
OM usher protein 
vgrG Actin cross-linking toxin VgrG1 fet A, B 
Iron export system 
elf A 
fimbrial sub-unit 
cmi Colicin-M immunity protein isc A Iron-binding protein 
flh A, B, C, D, E 
Flagella assembly 
ccdB Toxin CcdB fie F Ferrous-iron efflux pump 
figA, B, C, D, E, 
F, G, H, I, K, L, 
M, N 
Flagella components cvaA Colicin V secretion protein CvaA erp A 
Iron-sulfur cluster insertion 
protein 
filC, D, E, F, G, 
H, I, J, K, M, N, 
O, P, T, S 
Flagella components ykfI Toxin YkfI ytf E Iron-sulfur cluster repair protein 
pil E, T, Q 
Type IV system 
(Twitching) tab A, tabB Toxin-antitoxin biofilm proteins feo A, B, C Fe(2+) transporter 
yha K 
Prin-like protein cirA Colicin I receptor fec A Fe(3+) dicitrate transport protein 
cid A 
Holin-like protein symE Toxic protein SymE fhuA, B, C, D, F Ferrichrome uptake system 
pil Q 
Type IV pilus biogenesis 
  Metal resistance 
yd iV 
Anti-FlhC/FlhD factor Iron acquisition, transport and metabolism czcA Cobalt-zinc-cadmium resistance 
ycg R Flagellar brake protein 
fha B, C 
Filamentous hemagglutinin arsB, C, R Arsenate resistance 
out O Type 4 prepilin-like protein tiy C Hemolysin C corA 
Cobalt/magnesium 
transport 
Adhesin hmu T, U Hemin transport system  tehB 
Tellurite methyltransferase 





Flavohemoprotein rcnA Nickel/cobalt efflux system 
cdl4 Immunity protein shl B Hemolysin transporter csoR Copper-sensing transcriptional repressor 
phoQ Virulence sensor histidine kinase 
fep A, B, C, D, 
G Ferrienterobactin system znuA, B, C 
Zinc transport 
inlA Internalin-A ybd Z Enterobactin biosynthesis zntB Zinc transport 
eae 
Intimin ent A, B, E, F, 
S Enterobactin biosynthesis pcoC Copper resistance 
inv Invasin ccm B, C Heme exporter zitB Zinc transport 









binding protein hmu T, U, V 






Bacterial non-heme ferritin 
 
 
Isolation of ESBL producing bacteria. 
Page 76 of 137 
 
 
During infection, where iron is present at growth-inhibitory concentrations, bacteria have to 
be able to access iron from haemoglobin or iron proteins or ferritins. Both isolates contain 
multiple genes coding for hemolysin C (gene tiy C,) siderophores such as enterobactin 
(genes ent A, B, E, F, S) and aerobactin (gene iuc C) reference Table 12. However other 
siderophore genes are absent from these isolates (iuc A, B, and iut A), although its receptor 
aer is present. The potential use of enterobactin is clearer; where the Fep P outer 
membrane acceptor protein and the Fes esterase, necessary for cleavage of iron from the 
siderophore, are present (Table 12).  
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Table 12. Genes that code Virulence factors, adhesins, appendages and toxins in isolates EwS1 and EwB2. 
gene function gene function gene function 
mka B, C 28.1 kDa virulence protein, transcriptional 
activator flhA, B, C, D, E Flagellar assembly ccmB, C Heme exporter proteins 
vatD Streptogramin A acetyltransferase figA, B, C, D, E, F, G, H, I, K, L, M, N Flagellar components  hem S Hemin transport protein 
phoQ Virulence sensor histidine kinase 
filC, D, E, F, G, H, I, 
J, K, M, N, O, P, T, 
S 
Flagella components hmu T, U, V Hemin-binding, transport protein 
inlA Internalin-A pilE Fimbrial protein cbt A Cytoskeleton-binding toxin CbtA 
cdl4 Immunity protein CdiI-o11 yhaK Pirin-like protein YhaK cbe A Cytoskeleton bundling-enhancing protein CbeA 
eae Intimin cidA Holin-like protein CidA cir A Colicin I receptor 
inv Invasin pilQ 
Type IV pilus biogenesis and 
competence protein PilQ symE Toxic protein SymE 
yeeJ Invasin ydiV 
Putative anti-FlhC(2)FlhD(4) factor 
YdiV apxIB Toxin RTX-I translocation ATP-binding protein 




parE, D Toxin ParE1, Antitoxin ParD1 
tauA, B Taurine-binding periplasmic protein A, Taurine import ATP-binding protein TauB tiyC Hemolysin C higA, B Antitoxin HigA1, Toxin HigB-2 
yrfF Putative membrane protein IgaA homolog hmuU 
Hemin transport system permease 
protein cdiA Toxin CdiA 
yraI, H, K putative fimbrial-like protein YraK and YraH fepA, B, C, D, G 
Ferric enterobactin transport 
proteins cmi Colicin-M immunity protein 
smf Major fimbrial subunit SMF-1 fes Enterochelin esterase vgrG Actin cross-linking toxin VgrG1 
yadV putative fimbrial chaperone ybdZ Enterobactin biosynthesis protein  ccdB Toxin CcdB 
csgA, B, 
C, D, E Curli production elfA Fimbrial subunit ElfA cvaA Colicin V secretion protein CvaA 
fik Flagellar regulator ent A, B, E, F, S Enterobactin synthase ykfI Toxin YkfI 
lpfA, B major fimbrial subunit, fimbrial chaperone hmp Flavohemoprotein tabB Toxin-antitoxin biofilm protein TabA 
fimD OM usher protein FimD shlB Hemolysin transporter protein licB glycolipid that is a necessary component and antigenic determinant of the outer membrane 
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To colonise host tissue, bacteria must exhibit invasiveness. EwS1 and EwB2 have genes 
such as surface-sensing type 1 and/or type IV pili or fimbriae. It is not known whether 
isolates EwS1 and EwB2 exhibit flagella impairment, but they have the genes for type III 
flagella include the core operon (fhl D, C) and the fhl A, B, E operon for type III flagella 
where the fhl E gene product is thought to be important for swarming (McDowall et al., 
2014),. In addition to these operons, those responsible for flagella motor switch (fig G, M, 
N) and for general biogenesis of the flagella (Table 12) including gene fil C coding for a-
type flagellin. The genomes do contain genes that potentially code for pili and fimbriae, 
some of which have been implemented in adhesion of bacterial cells to human cells. The 
yra H, I, J, K operon (Table 12) codes for a type 1 fimbria adhesin. Another type 1 fimbria 
involved in adhesion in enteropathogenic E. coli infections is the long polar fimbria, coded 
for by the lpf ABCDE operon (Ideses et al., 2005). Other genes present in the genomes that 
could be involved in adhesion include smf-1, a major fimbrial sub-unit that can mediate 
agglutination of red blood cells (de Oliveira-Garcia et al., 2003), fim D, an outer membrane 
protein, and elf A, the major fimbrial sub-unit of the elf ADCG-ycbUVF operon that is 
involved in adhesion to abiotic substrates (Korea et al., 2010). It is unknown whether any of 
these gene form active products. Within members of the Enterobacterales, the curli fimbriae 
are encoded into two divergent operons, csg C, A, B and csg D, E, F, and G. The genomes 
of isolates EwS1 and EwB2 have these operons in a similar arrangement.  
Genes coding for tissue invasion are present in the genomes of EwS1 and EwB2. 
Surprisingly, isolates EwS1 and EwB2 have more than one type of adhesion protein capable 
of being expressed in their genomes. Three adhesin genes including invasion genes (genes 
inv and yeeJ), intimin genes (eaeA) or internalin genes (inl A) are present in the genomes 
(Table 12).  
The invasin gene was present in both genomes several times while the intimin and internalin 
genes are commonly found in bacteria belonging to different taxonomic groups, suggesting 
that the presence of all these genes was due to horizontal transfer. This notion is borne out 
by the phylogenetic relationship shown by the different invasion genes (Figure 32), where 
the inv gene groups with members of the Yersiniaceae while the yee J gene is found with 
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Figure 32. Maximum likelihood phylogenetic tree showing the relationship of the invasin gene 
sequences (Inv and yeeJ) from isolates EwS1 and EwB2 (Boxed) with those from other members of 
the Enterobacterales.  The maximum likelihood model used to construct the tree was GTR+I+G with 
an estimated P-INV value of 0.089062, and this generated a tree of -In L = 11655.63330 from 687 
distinct data patterns. 
  
ESBL Isolates 
Isolation of ESBL producing bacteria. 
Page 80 of 137 
 
It is possible that the isolates EwS1 and EwB2 are capable of invading epithelial cells via a 
number of routes, although a gene for TIR was not identified suggesting that adhesion via 
the intimin route might not be feasible.         
The acquisition of sulfur and nitrogen is essential for growth once colonisation has occurred. 
Both isolates have the genes coding for enzymes and proteins involved in ammonia, nitrate 
and nitrite assimilation and respiration (nar I, J, H, G, K, L, X, nar D, nas D), as well as those 
for acquiring glutathione (genes gsi A, B, C, D) and urease, but they did not appear to have 
genes coding for nitrogen fixation functions. Inorganic and organic sulfur is available in the 
human body, with levels of 215.5 µM sulfate, 100.8 µM thiosulfate, 37 µM glutathione, 62 
µM cystine and 55.5 µM taurine present in the plasma (Lensmire et al., 2019). The isolates 
had approximately 32 identified genes involved in sulfur metabolism. These included genes 
for sulfate, thiosulfate and sulfite acquisition and metabolism (cys A, B, C, D, H, M, N, P, T, 
W, Z, rhd A, dsb A, B, E, dbd C, D genes) including cysteine synthesis, glutathione 
acquisition and metabolism (gsi A, B, C, D, yei G, frm A genes), and those responsible for 
the acquisition of taurine, 2-aminoethanesulfonic acid, (tau A,B,C, D genes) and other 
sulfonated substrates such as alkanesulfonates and substituted ethanesulfonic acid (ssu E, 
A, D, C, B genes) reference Table 10, 11 and 12. 
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4.0 Isolation of bacteriophages for specific bacteria isolated 
from wastewater. 
4.1 Introduction 
Viruses are the most abundant life forms on Earth, with estimated global number of 1031 
particles or virions, which is 10 times greater than the number of bacterial cells (Willianson 
et al., 2005, Weitz et al., 2012, Güemes et al., 2016).  Twort (1915) and D’Herelle (1917) 
discovered bacterial viruses independently, both of whom realised that an entity existed 
with the ability to lyse bacterial cells. It was D’Herelle that gave this entity the name 
bacteriophage, describing it as a virus, and developed methods for its enumeration. Also, 
he proposed the use of bacteriophages as therapeutic agents and as prophylactics, 
introducing the concept of phage therapy (D’Herelle, 1926). Commercial preparations of 
bacteriophages first became available in the nineteen thirties, but their consistency and 
quality were variable, and this, amongst other reasons, promoted sceptical reporting about 
the medical uses of phages (Summers, 2012). During this period, sulphonamides drugs 
were used to treat infections with success, which appeared to have a greater consistency 
and simplicity than viral treatments. Furthermore, medicine in Europe and the USA was 
about to enter the golden era of antibiotic discovery and use, with the development of 
penicillin as a broad-based anti-bacterial treatment. During this period, research into phage 
therapy was performed only in the Soviet Union, particularly at the Tbilisi Institute Georgia 
(now the George Eliava Institute), and, to a lesser extent, Germany (Summers, 2012). 
Eventually, world medicine, human and veterinary, became dependent on antibiotics as the 
main therapeutic and prophylactic agents against bacterial infections. This has been the 
case until now. The world-wide spread of resistances to most clinically useful antibiotics by 
pathogenic and environmental bacteria has led to a re-emergence of an interest in 
bacteriophage therapy (Kortright, 2019). 
In the current study, the research focus was to isolate and characterise bacteriophages 
specific to ESBL-producing bacteria recovered from sewage - a rich source of 
enterobacteria and their viruses. The discovery of such viruses would be of particular 
interest because they are a potential replacement, or adjuvant, to antibiotics for the 
treatment of skin ulcers, wounds, burns, allergies, gastrointestinal ailments, methicillin-
resistant Staphylococcus aureus infections (Abedon et al., 2011). In addition, they have 
also been used as biological control agents, reducing bacterial loads in foods, such as that 
of Listeria monocytogenes in food processing (Bai et al., 2016), and of zoonotic pathogens 
in livestock (Atterbury, 2009), or, in the treatment of crops to control the incidence of plant 
pathogenic bacteria (Buttimer et al., 2017). This chapter describes the isolation of phages 
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for ESBL-producing Klebsiella pneumonia ATCC 13883, Pseudomonas [Isolated from 
wastewater], Escherichia coli (strains 1-6 isolated from wastewater and E. coli K802) and 
the two novel bacteria related to the members of the genus Rahnella. Moreover, their 
specificity and transmission electron microscopy (TEM) study of selected isolates would be 
described.   
4.2 Isolation of bacteriophages  
As described in the previous chapters, different bacteria have been isolated, identified, and 
characterised. In the next step, bacteriophages that can kill these bacteria have been 
isolated and characterized. Phages were, isolated using the one-host enrichment method. 
In this approach wastewater is mixed with a culture of each isolated strain to obtain the 
lysate containing a population of bacteriophages capable of infecting these cells (Chapter 
2.7.2). The resulting plaques observed were named according to their host bacterium, size, 
and morphology. In total, 5 different bacteriophages of E. coli, Pseudomonas and the cold 
tolerant bacterial strains were obtained. The isolated bacteriophages were named as EcC1, 
PsBT1 and PsST2 according to host bacterium E. coli (Ec) or Pseudomonas (Ps) and 
plaque type clear (C) or turbid (T) and size (B for big or S for small). Specifically: EcC1 
produced round, clean edged clear plaques with an average size of 0.2 mm ± 0.2 mm. 
PsBT1 and PsST2 both produced a rough, haloed edged turbid plaques. They had an 
average size of 1 mm ± 0.3 mm for PsBT1 and 0.6 mm ± 0.2 mm for PsST2, while the 2 
phages isolated for the cold tolerant bacteria were named EpC1 and EpT2 respectively for 
the clear and turbid varieties. The first had clear plaques of diameter 1.5 mm ± 0.5 mm with 
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4.2.1 Phage specificity 
The 5 different bacteriophages were isolated as plaques formed on lawns of ESBL-
producing bacteria. To determine their host range, bacteriophages EcC1, PsBT1 and 
PsST2 were tested against different bacterial strains at 37oC, whilst for the cold tolerant 
EwS1 and EwB2 strains, not able to grow at 37oC, their bacteriophages EpC1 and EpT2 
were tested against different bacterial strains at 30oC.  It was found that phages EpC1 and 
EpT2 propagated efficiently in both EwS1 and EwB2 strains and were not able to infect 
Pseudomonas and E. coli strains isolated from wastewater, nor the laboratory strains such 
as Serratia marcescens (ATCC 17 AW), Klebsiella pneumonia (ATCC 13883), Proteus 
mirabilis (ATCC 7002), E. coli K802 or Hafnia alvei (Table 13). Thus, these bacteriophages 
exhibited high specificity for their host. It was concluded that these bacteriophages are 
specific to only EwS1 and EwB2 strains newly isolated from treated wastewater. Moreover, 
it was observed that EcC1 efficiently propagated in all E. coli strains and PsBT1 and PsST2 
bacteriophages on one of the Pseudomonas strains (strain 1).  The three phages were 




Figure 33. Images of EpC1 (A) and EpT2 (B) plaques on agar plates. Images obtained using Gel 
Doc™ XR system (Bio-Rad). The plaques represent zones of clearing of bacteriophage on bacteria 
lawn. Arrows indicate clear plaques and arrowheads the turbid variety. 
A B 
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Table 13. Propagation of all isolated bacteriophages on different bacterial strains 
 Bacteriophages    
Bacterial Strains EpC1 EpT2 EcC1 PsBT1 PsST2 
*EwS1 + + ̶ ̶ ̶ 
*EwB2 + + ̶ ̶ ̶ 
*Pseudomonas 
strain 1 
̶ ̶ ̶ + + 
*Pseudomonas 
strain 2 
̶ ̶ ̶ ̶ ̶ 
*Pseudomonas 
strain 3 
̶ ̶ ̶ ̶ ̶ 
*Pseudomonas 
strain 4 
̶ ̶ − ̶ ̶ 
*E. coli strain 1 ̶ ̶ + ̶ ̶ 
*E. coli strain 2 ̶ ̶ + ̶ ̶ 
*E. coli strain 3 ̶ ̶ + ̶ ̶ 
*E. coli strain 4 ̶ ̶ + ̶ ̶ 
*E. coli strain 5 ̶ ̶ + ̶ ̶ 
*E. coli strain 6 ̶ ̶̶ + ̶̶ ̶ 




̶ ̶ ̶ ̶ ̶ 
Hafnia alvei UoP 
culture collection 




̶ ̶ ̶ ̶ ̶ 
Proteus mirabilis 
ATCC 7002 
̶ ̶ ̶ ̶ ̶ 
• (+) Growth 
• (-) No-growth 
• (*) Bacteria isolated from sewage. 
 
4.2.2 Effect of divalent cations on phage growth 
The formation of plaques by phages EpC1 and EpT2 on complete media without the 
addition of divalent cations was observed, and therefore the following experiments done in 
triplicates were designed to test whether phage propagation could be improved by cations 
addition. Phage growth was investigated in the presence of different concentrations of Ca2+ 
and Mg2+: 0 mM, 2 mM, 5 mM and 10 mM. In the absence of Ca2+ and Mg2+ ions the titers 
of phage EpC1 and EpT2 stocks were 5.0 X 106 and 1.3 x 106 pfu/ml (Table 14).  Variation 
in calcium and magnesium ion concentrations influenced phage propagation significantly. 
Increasing the Ca2+ concentration to 10 mM resulted in a 34-44 times increased plaque 
formation for both phages (Figure 34a), whereas increasing the Mg2+ to 10 mM improved 
plaque formation by 5-7 times (Figure 34b). Given that inclusion of calcium had the greatest 
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effect on plaque formation, it was included at (10 mM) as a supplement in all subsequent 




Figure 34. Influence of divalent cations on the growth of phages EpC1 and EpT2 done in triplicate. 
(a) Calcium chloride concentration and (b) Magnesium sulfate concentration. The viral yield was 
plotted against the concentration of the cations. the graphs show that calcium cation is the better 
propagator for bacteriophage EpC1 and EpT2, with very significant increases in viral yields at 5- AND 
10-MM concentration.  
(b) 
(a) 
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Table 14. Phage progeny production in liquid medium containing different concentration of divalent 
cations. 
CaCl2 and MgSO4 
concentration, mM 
Phage titer (pfu/ml)  
EpC1 Standard Error EpT2 Standard Error 
2 mM CaCl2 8.0 X 106 1.15 X 105 7.7 X 106 ± 105 
5 mM CaCl2 5.1 X 107 1.73 X 106 1.2 X 107 ± 106 
10 mM CaCl2 2.2 X 108 1.73 X 107 4.5 X 107 ± 106 
2 mM MgSO4 9.0 X 106 3.53 X 105 6.0 X 105 ± 104 
5 mM MgSO4 6.0 X 106 1.53 X 105 2.1 X 106 ± 105 
10 mM MgSO4 3.5 X 107 2.89 X 106 6.8 X 106 ± 105 
Control (No CaCl2 or 
MgSO4) 
5.0 X 106 1.15 X 105
  
1.3 X 106 ± 105 
 
4.2.3 High titer lysate preparation of bacteriophages 
In order to further study the bacteriophages of the cold tolerant bacteria EwS1 and EwB2 it 
was necessary to improve their working stock titers. This can be achieved by incorporating 
a concentration stage during their isolation. Traditional concentration methods include 
ultracentrifugation, density centrifugation, or phase separation using polyethylene glycol 
(PEG).  The titer of bacteriophage stocks prepared directly from agar plates ranged from 7 
to 8 log PFU/ml. To improve this recovery, a PEG phase separation was employed where 
PEG 6000 (10 %) and NaCl (0.5 M) were added to the lysate followed by precipitation of 
the virions by centrifugation. This resulted in a 100-fold increase in the viral titer after the 
virions were resuspended in a buffer (Table 15).  
Table 15. Comparison of bacteriophage titer before and after PEG6000 precipitation. 
 
Phage 
Phage titer (pfu/ml) 
 






2.34 x 108 4.12 x 1010 
2.2 x 108 5.6 x 1010 
3.59 x 107 1.73 x 109 
3.7 x 107 6.0 x 109 
 
4.2.4 Restriction profile analysis of the bacteriophages 
Restriction analysis of EpC1 and EpT2 bacteriophages was carried out to determine 
whether they are different from each other. DNA was extracted from high titer viral stocks 
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(as described in chapter 2.7.10) and subjected to digestion with Bgl II. The restriction 
fragments were separated by agarose gel electrophoresis. The results presented on Figure 
35 showed that the patterns of Bgl II restriction digestion profiles for EpC1 and EpT2 
bacteriophages were different, indicating that these phages were distinctive isolates. 
Furthermore, restriction endonucleases cut only double-stranded DNA, consequently 

















Figure 35. (A) An example of agarose gel electrophoresis of Bgl II digested bacteriophage DNA 
EpC1 and EpT2, (B) Promega provided image of DNA ladder band pattern. Lane 1: native DNA 
EpC1 before digestion, Lane 2: DNA EpC1 digested by Bgl II enzyme, Lane 3: 1 kb DNA-ladder 
(Promega), Lane 4: DNA EpT2 digested by Bgl II enzyme, Lane 5:  native DNA EpT2 before digest. 
 
4.2.5 Transmission Electron Microscopy 
The morphology of the EpC1 phage was determined by transmission electron microscopy 
analysis (Figure 36) using 2 independently isolated stocks. Electron microscopy analysis of 
EpC1 showed an icosahedral head measuring 64 nm and a long, flexible, noncontractile tail 
that is 167 nm in length and 18 nm in width, similar to the average size of noncontractile 
tails (Appendix 8). No tail fibers were observed. The phage head is supposed to be filled 
with double stranded DNA based on DNA digest data (chapter 4.2.4). Based on the 
obtained TEM images this bacterial virus could belong to the Siphoviridae Family. 
1       2      3      4      5     A B 
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Figure 36. A. Transmission Electron Microscopy image of a bacteriophage, which exhibits an 
icosahedral head, long non-contractile tail. This morphology corresponds to the Siphoviridae Family. 
Bar, 100 nm. Magnification, x30000. B. Enlarged image of phage EpC1 showing its dimensions. 
In summary, 12 bacteria were isolated from wastewater. Six of them carried genes 
responsible for antibiotic resistance (CTX-M and TEM genes). Two of the isolates (EwS1 
and EwB2) were characterised extensively and the results suggested that these bacteria 
were novel and belonging to a new genus of the Enterobacteriaceae family.  
Five bacteriophages were also isolated from the wastewater. Two of these were strain 
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5.0 Discussion and conclusions 
The present study describes the discovery of two novel cold tolerant environmental bacteria 
EwS1 and EwB2 containing ESBL genes (CTX-M and TEM) and virulence factors, thus 
posing potential environmental and human health risks. They belong to Enterobacteriaceae 
family and have close phylogenetic matches to Ewingella americana and Rahnella species. 
Also, 10 more different bacteria were isolated from wastewater sampled from the Southern 
water treatment site at Petersfield. Six isolates were identified as belonging to E. coli 
species and 4 belonging to Genus Pseudomonas. 
These two novel cold tolerant bacteria (EwS1 and EwB2) are environmental species that 
could be cohabitants with plants but have acquired multi-drug resistance to 5 out of 13 
tested antibiotics. This is of interest as such bacteria can resist some treatments used in 
water treatment plants and serve as an exposure route to humans. ESBL genes in these 
bacteria are encoded on plasmid and can easily be transferred to other species that can be 
pathogenic to humans. It is known that genes associated with mobile elements facilitate 
their spread in the population and horizontal transfer to other organisms (Cornejova et al., 
2015). 
It was observed that CTX is the predominant gene compared with TEM (ratio 6:2) among 
all 12 isolated strains. SHV and OXA groups genes were also analysed but no gene 
presence was seen. There is a possibility that the primers used for identification of these 
genes did not perform adequately and therefore that this is a false negative result. However, 
it is more likely that no amplification was seen because these genes are rarely present, as 
literature suggests (Bonnet, 2003). The molecular biological and microbiological analyses 
of these two strains suggest that they constitute a new bacteria taxon that could not be 
assigned to any known genus.  
It was considered necessary to classify the unknown bacteria because of its unique 
molecular, physiological, and biochemical characteristics. These bacteria which are 
mesophilic but could grow at low temperature looked to be a plant symbiont but contained 
several genes that allowed it to be pathogenic. It also had antibiotic resistance genes, 
inavsin genes, all which are associated with pathogens. This identification and 
characterization have become increasingly important because it was discovered in sewage 
treatment plant, where this treated effluent is expected to be free of microbes. This reveals 
that this effluent can serve as infection route to humans and water recycled to the 
environment containing such microbes can produce biofilms and survive on plants and 
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because the antibiotic resistance genes are encoded on plasmids, they can easily be 
transferred to other human pathogenic bacteria.  
Identifying virulence genes from genome sequence information can be risky and should be 
accompanied by experimental work (Wassenaar and Gaastra, 2001). Considering this, it is 
difficult to conclude whether isolates EwS1 and EwB2 represent pathogens, capable of 
surviving temperatures above and below their growth optimum and producing 
thermoresistant proteins (chapter 3, Table 10), and they have acquired genes coding for 
functions that would enable them to survive in human tissue.  
One of the great challenges for a bacterium colonising animal tissues is the acquisition of 
iron, which is essential for growth. The concentration of free iron in the human body is 
estimated to be 10-18 M, which is several orders below that required (10-6 M) for bacterial 
infection (Braun et al., 1998). In natural, pH-neutral environments iron is present in its ferric 
form as insoluble hydroxide or oxyhydroxide precipitates. Mammalian cells have high 
binding affinity glycoproteins, transferrin and lactoferrin, to help solubilise and deliver iron, 
which helps protect the cell from the toxic effects of iron overload. Over one half of the iron 
in human bodies is locked up in haemoglobin present in blood cells, with the rest being 
stored in the ferritins. It is unsurprising to find that infecting bacteria target these for their 
iron needs. 
All bacteria need to have a number of strategies to handle iron, whether they are pathogens 
or not, in order to avoid the toxic effects of the metal (Frawley and Fang, 2014). The cell 
has to maintain a balance of iron within the cytoplasm so that it does not reach a level that 
can cause damage from the Fenton reaction. The expression and exportation of 
siderophores, and other iron import systems, allow iron to be acquired from the 
environment. Iron transported into the cell is incorporated into iron-sulfur cluster and 
mononuclear iron proteins as well as being sequestered by ferritin. The storage of iron in 
this way prevents its build up within the cytoplasm. Additional iron can be further 
sequestered by the DNA-binding protein Dps. When stressed, iron can be mobilised from 
these storage units and exported by iron efflux systems to balance the metal concentration 
within the cell. The genomes of isolates EwS1 and EwB2 have conserved genes that code 
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Figure 37. Iron transport in isolates EwS1 and EwB2. When intracellular iron levels are low (left), 
cells express siderophores and other iron import systems to acquire iron. Under iron replete 
conditions, the iron-sensing transcriptional regulator Fur represses the expression of iron acquisition 
genes. Available iron is incorporated into iron-sulfur cluster and mononuclear iron proteins, and 
excess iron is sequestered by ferritin (right). Additional iron can be sequestered by the DNA-binding 
protein Dps. Under stress conditions in which iron is mobilized from proteins, iron exporters, 
predicted to be localized in the inner membrane, promote iron efflux to mitigate DNA damage from 
Fenton chemistry. Redrawn from Frawley and Fang (2014). 
 
During infection, where iron is present at growth-inhibitory concentrations, bacteria have to 
be able to access iron from haemoglobin or iron proteins or ferritins. Siderophores such as 
enterobactin and aerobactin are capable of binding ferric ion with great efficiencies (Carrano 
and Raymond, 1979; Meyier, 1999), and aerobactin has been associated with urinary tract 
infections.   
One of the most important virulence factors of pathogenic bacteria is the formation of 
biofilms. Biofilms are aggregations of cells or microbial communities attached to a surface 
and encased in an extracellular matrix mainly composed by extracellular polymeric 
substances (EPS) (Harper et al., 2014, Guo et al., 2014). Around 15 % of bacteria can 
survive in biofilms after treatment with chemicals, antibiotics or host immune system, 
Fur 
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reproducing potentially harmful toxins after treatment. An example of bacteria surviving after 
treatment with chemicals was reported in Luna-Guevara et al., 2019 where they reported 
531 cases of illness, including one death, related to the consumption of contaminated fruits 
and vegetables between 2008 and 2010. EwS1 and EwB2 have genes responsible for EPS 
production. Therefore, these bacteria can produce biofilms that can stick to growing plants 
even after treatment. Also, because these bacteria are cold tolerant and can produce 
biofilms and toxins, thus food kept in fridge can still be at risk of spreading infections, if not 
properly washed. This ability of bacteria to form biofilms represents a serious medical 
challenge. Therefore, there is a need to identify and develop therapeutic strategies to 
eradicate bacteria producing biofilms.  
The curli fimbriae form the major proteinaceous part of the extracellular matrix, which may 
also comprise cellulose and/or polysaccharides to give the characteristic colony 
morphology. Curli are also important in the formation of biofilms, specifically allowing 
Salmonella enteriditis to adhere to Teflon and steel (Barnhart and Chapman, 2006).  
Marginal evidence exists in EwS1 and EwB2 for the presence of type IV pili involved in 
twitching mobility (Mattick, 2002) with the presence of the genes out O (pre-pillin), pil Q 
(secretion protein for pili extension) and pil T (mobility protein). There is also some evidence 
to suggest that the genomes contain genes coding for a type II section system (Korotkov et 
al., 2012), important in the translocation of proteins across the periplasm in gram negative 
bacteria. It is unsurprising to find genes for these systems within these genomes as they 
are present in all members of the Enterobacterales, which may or may not be involved in 
tissue invasion. 
Within the genomes of isolates EwS1 and EwB2 there are multiple copies of lpf A and ipf 
B, which code for the major fimbrial subunit and the chaperone but not genes lpf C (usher 
protein), D (minor subunit) or E (adhesin). This suggests that this operon has been 
introduced by horizontal transfer and lost many times during the evolution of these bacteria. 
Other genes such as the yra H, I, J, K operons exported by the chaperone/usher pathway 
is implemented in the binding to environmental abiotic factors as well as improving bladder 
and epithelial cells attachment in the absence of the flm operon (Korea et al., 2010). Genes 
coding for either invasion (genes inv and yeeJ) or intimin (eaeA), are commonly associated 
with members of the Yersiniaceae or the Enterobacterales (Isberg et al., 2000; while 
internalin (inl A) is associated with Listeria monocytogenes, a gram-positive bacterium, 
infections (Braun and Cossart, 2000).   
Pathogenic bacteria belonging to the Yersiniaceae or Enterobacteriaceae target specialised 
epithelial cells, known as M cells, that are located in lymphoid tissue known as Peyer’s 
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patches. The function of M cells includes endocytic and phagocytic uptake of particles that 
are then transferred to intraepithelial pockets for the attention of T and B cells and 
macrophages. Pathogenic bacteria can use this uptake to gain access to the lymphoid 
system from where they can be distributed around the body (Palumbo and Wang, 2006).  
The three proteins present for tissue invasion attach to target cell by different mechanisms 
(Figure 38), although all three proteins promote the accumulation of actin beneath the 
attached cell that initiates phagocytosis.  
 
Figure 38. Various bacterial pathogens and their mechanisms for stimulating membrane protrusion. 
Listeria monocytogenes adheres to host cells via the binding of a bacterial surface protein, internalin 
A (IlnA) to E-cadherin. E-cadherin, via Rac activation, can trigger dynamic events of actin 
polymerization and membrane extension, culminating in bacterial uptake. Yersinia expresses invasin 
on its surface, which binds with high affinity toα 5β1 integrins. Yersinia uptake requires Rac1 and the 
Arp2/3 complex. EPEC attach to host cells through translocated intimin receptor (TIR), a receptor 
secreted by EPEC and inserted into the host cell plasma membrane where it acts as a receptor for 
intimin. WASP and the Arp2/3 complex are recruited to sites of attachment and stimulate actin 
polymerization required for pedestal formation (DeMali and Burridge, 2006). 
Internalin is a bacterial surface protein that binds to E-cadherin on the surface of the M cell 
initiating actin polymerisation and phagocytosis via the zippering mechanism (DeMali and 
Burridge, 2006). Invasin is another bacterial surface protein that has a high binding affinity 
to β1 integrins (Isberg et al., 2000), where uptake of the cell requires the host protein RAC1 
and the ARP2/3 complex (Figure 38). In contrast, intimin is an adhesin protein that binds to 
a receptor (translocated intimin receptor, TIR) on the host membrane that has been inserted 
by the bacterial cell after it has been expressed and translocated (Figure 37). The binding 
of intimin at the receptor stimulates actin reorganisation to form a pedestal structure that 
can extend up to 10 µm beneath the pathogen (Goosney et al., 2001).  
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Interestingly, in Escherichia coli the expression of genes for sulfonate metabolism, is 
depressed in the absence of sulfate or cysteine, and the deletion of tau A, B or C genes 
results in the cell losing the ability to grow on minimal media supplemented with taurine, but 
not other sulfonates (Eichhorn et al., 2000). Taurine is a major constituent of bile and it is 
present in the large intestine, amongst other organs, and accounts for up to 0.1% of total 
human body weight (Schuller-Levis and Park, 2003). It is, therefore, a potential source of 
carbon, nitrogen and sulfur for microbes (Cook and Denger, 2006) infecting animal bodies. 
The presence of the tau A, B, C and D genes in EwS1 and EwB2, however, does not 
necessarily reflect that the organism has a pathogenic life strategy. Taurine is a common 
molecule released into the environment by mesozooplankton (Webb and Johannes, 1967) 
and algae (Tevatia et al., 2015), and it is a major source of carbon and energy in marine 
environments (Clifford et al., 2019). This would be unsurprising given the linkage of EwS1 
and EwB2 to the genus Rahnella, which contains known symbionts of plants that have the 
ability to fix atmospheric nitrogen, a diagnostic feature of the genus. Rahnella aquatilis has 
a 38-kDa major outer membrane protein that functions as a root adhesin and porin (Achouak 
et al., 1998). This protein shares a high sequence similarity with those (ompC and ompF) 
from gram-negative pathogens, leading to the suggestion that this adhesin may mediate 
adhesion to epithelial cells during bacteria invasion.  
Given that EwS1 and EwB2 have several virulence genes, these bacteria could potentially 
be risky to human health. Moreover, the presence of ESBLs and multi-drug resistant genes 
in EwS1 and EwB2, which can be easily transferred to different pathogenic species, is 
another source of danger to humans. Importantly, the fact that the EpC1 and EpT2 viruses 
were found in sewage suggests that the quantity of the discovered EwS1 and EwB2 bacteria 
live there is enough for populations of viruses to build up. These newly identified phages 
could be used for treatment or for adjuvant treatment of infection caused by EwS1 and 
EwB2 ESBL producing multi-drug resistant bacteria. Therefore, these bacteriophages 
specific to EwS1 and EwB2 were characterized further. 
The diversity of bacteriophages in wastewater is great and this environment is a rich source 
for discovering novel viruses (Jurczak-Kurek et al., 2016). In this study, 5 different 
bacteriophages were isolated from wastewater samples. Two isolates infected 
Pseudomonas species, one infected Escherichia coli, and two infected a cold tolerant 
bacterial strain that had been isolated from the same wastewater treatment plant.  These 
bacteria belong within the Enterobacteriaceae (see Chapter 1) but are novel with their 
closest phylogenetic matches to Ewingella americana and Rahnella species. These 
bacteria are primarily environmental species interacting with plants; however, they can be 
pathogenic to humans and they have acquired multi-drug resistance. There are no reports 
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of viruses infecting these bacteria, but the DSMZ microbiology culture collection offers 
phages that infect Rahella variigena (DSM 108139) and Ewingella americana (DSM 4580). 
Both of these phages, Rahnella phage vB RvaM-O238 (DSM 108187) and Ewingella phage 
PT-JD18 (DSM 27304), belong to the Mycoviridae.  
These identified phages EpC1 and EpT2 are novel viruses that specifically infect novel cold 
tolerant bacteria. Appendix 8 lists 52 genera belonging to the Siphoviridae, describing the 
basic characteristics such as their morphology, genome size and main host. The 
morphology of phage EpC1 falls within the range for head and tail dimensions observed in 
Appendix 8, these phages are distinctive isolates as shown by different restriction digestion 
patterns. But, for these genera, there is no exact match, particularly for a host. Care should 
be taken here, however. The genera listed represent only about 20% of those described for 
the Siphoviridae, which currently total 265 genera. Furthermore, the majority of these 
genera comprise a single or two species, with only 36 that have been classified into higher 
orders and 9 that contain more than 10 species (https://talk.ictvonline.org/taxonomy/). The 
novelty of phages EpC1 and EpT2 lies in their limited host range, and the observation that 
these are the only described species likely to belong to the Siphoviridiae that infect bacteria 
belonging to the Ewingella & Rahnella group.  
These bacteriophages can be used in controlling bacterial plant pathogens. The main 
determining factor whether a phage can be appropriate for biocontrol is whether a phage is 
exclusively lytic (virulent) or temperate in nature. Preferably a phage for biocontrol 
applications should be exclusively lytic and possess a host range which allows productive 
infection on all strains of the pathogen genus/species being targeted (Buttimer et al., 2017). 
The current opinion is that phages should produce high numbers of new phages quickly 
while lysing the host cell and diffusing easily though the environment to which they are being 
applied. Although in invitro studies, a phage may show great potential for phage infection, 
this is not always translated into biocontrol potential in the field (Buttimer et al., 2017). An 
example is one study by Balogh (2006) where 2 out of 3 phages of X. citri pv citri showing 
lytic activity invitro were unable to lyse their host bacterium on grapefruit leaves. In deciding 
which phage will be applicable for biocontrol, care should be taken to the receptors that a 
given phage recognizes on a bacterial target as this can assist in the making of phage 
cocktails with a reduced possibility of bacterial resistance. The individual members of this 
phage cocktail can work in synergy to eliminate the target bacterium (Frampton et al., 2014; 
Born et al., 2011).  
However, with temperate phages, the phage genome replicates as part of the bacterial 
genome of its host until a trigger switches it into the lytic cycle. These triggers can be 
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chemical or physical (UV light or heat) in nature (Buttimer et al., 2017; Muller et al., 2012). 
Sato (1983) also suggested that certain plant extracts can also trigger these events. In some 
cases, the presence of some genes on phage genomes can increase the fitness of their 
bacterial host. One example was reported by Evans et al., 2010 where the P. 
atrosepticum prophages ECA41 and ECA29 both improved the motility of their bacterial 
host. However, there are concerns with using temperate phages because these prophages 
can also harbor genes for toxins, examples are shiga, and cholera toxins Another concern 
is in the spread of virulence genes by transduction, where these phages can remove 
themselves from their host genomes incorporating host DNA into their own genomes 
facilitating horizontal transfer of genetic material among bacteria (Abedon and Lejeune, 
2005; Griffiths et al., 2000).  
Bacteriophages have evolved various virion-associated carbohydrate active enzymes, 
termed EPS depolymerases, that recognize, bind, and degrade the EPS to gain access to 
bacterial cell surface receptors. The clear phages appeared to be typical of virulent phages, 
while turbid phages may be temperate or a virulent phage that can produce plaque halos 
by the enzymatic activity of a phage-encoded EPS depolymerase. Such phages can 
produce cloudy clearings not as a direct consequence of phage population growth, but by 
extra-virion diffusion along with virion-free enzymatic degradation of bacteria. These 
enzymes do not degrade the whole bacterium but instead just exterior layers that are 
bacterium produced and associated (Abedon, 2011). According to Drulis-Kawa et al., 2015 
phage depolymerases appear in two forms: (i) as integral components of the phage particles 
or (ii) as soluble enzymes generated during host cell lysis. Association with virion particles 
allows for EPS depolymerase utility during the adsorption process, that is, as moving 
towards bacteria, whereas soluble enzymes are useful particularly in the moving away from 
bacteria. The depolymerase activity is commonly identified by a constantly increasing halo 
surrounding the phage plaques (Pires et al., 2016). Plaques produced by EPS 
depolymerase can be turbid. EpT2 was observed to have similarities to plaques produced 
as a result of EPS depolymerase activity. A mixture of bacteriophages can be used on the 
novel bacteria, where one phage encoding EPS depolymerases destroys the biofilm 
produced by bacteria while the other with lytic characteristics attacks and lyses the bacteria. 
Divalent cations are needed for bacteriophage growth of EpC1 and EpT2. They are required 
for viron stability, for phage adsorption and, for viral genome penetration (Marks and Sharp, 
2000; Karnik and Gopinathan, 1980), as well as for intracellular growth. The presence of 
the optimal concentration of divalent cations in adsorption buffers and media will determine 
the successful handling of the virus.  Calcium and, to a lesser extent, magnesium are the 
cations universally required by phage for their growth (Jończyk et al., 2011, Kutter and 
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Goldman, 2008), and it was found that increased concentrations of these cations are indeed 
required for the peak phage propagation. Typical concentration of calcium in sewage is 20 
to 120 mg/L. The concentration at any one tank will vary, particularly with pH, but it will also 
vary within a tank depending on the level of electrochemical phosphorus recovery. To 
reconcile the shortage of mined phosphorus and the overabundance of it in wastewater, the 
phosphorus is removed and reused by formation of amorphous calcium phosphate (Lei et 
al., 2018). 
Generation of progeny for EpC1 and EpT2 bacteriophages at low temperatures could be of 
particular applicability, for example in wastewater treatment. Host specificity is central to 
selection of suitable phages for wastewater treatment applications. Success would depend 
on accurate identification of problem, effective isolation and unbiased enrichment of phage 
and ability of phage to penetrate and remain infective in in situ condition (Periasamy and 
Sundaram, 2013). Biological hazard in water resources in the form of pathogenic organisms 
are responsible for major outbreak in most of the developing countries. Therefore, every 
effort leading to reduction in sewage pollution and pathogenic microbes must be promoted 
and implemented. This will not only safeguard the interest of the people but also help to 
maintain healthy and sustainable environment. Entry of antibiotic resistant pathogens into 
the sewage is inevitable as survival is the key for existence. Development of multidrug 
resistant bacteria and exit of many antibiotic companies necessitates to search for novel 
approaches to tackle the multidrug resistant bacteria. Phage therapy is an alternate to 
overcome these menacing organisms. 
Furthermore, foodborne illnesses remain a major cause of hospitalization and death 
worldwide despite many advances in food sanitation techniques and pathogen surveillance. 
Such was the case as British scientist discovered that bagged salad could fuel the growth 
of food-poisoning bugs like salmonella and make them more dangerous (Moye et al., 2018). 
Traditional antimicrobial methods, such as pasteurization and autoclaving processing are 
capable of reducing microbial populations in foods to varying degrees, but they also have 
negative impacts by reducing nutritional value of foods, killing many beneficial bacteria that 
are naturally present in foods. So, the interest for natural antimicrobial compounds has 
increased also due to alterations in consumer attitudes towards the use of chemical 
preservatives in foodstuff and food processing surfaces (Moye et al., 2018). Bacteriophages 
fit in the class of natural antimicrobials and their effectiveness in controlling bacterial 
pathogens in agro-food industry has led to the development of different phage products 
already approved by USFDA and USDA (Sarhan and Azzazy, 2014). Treatment with 
specific phages in the food industry (Leverentz et al., 2003, Bren, 2007) can prevent the 
decay of products and the spread of bacterial diseases and ultimately promote safe 
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environments in animal and plant food production, processing, and handling (Sillankorva et 
al., 2012). Work presented in this thesis makes novel contribution to this endeavour as it 
potentially offers new tools for environmentally safer treatment to overcome the alarming 
threat of antibiotic resistant bacteria. 
Although significant findings were produced, limitations within this study must be 
considered. The first is the average utilization (average well colour development) of the 
carbon sources in the plates was not obtained using optical density as a measure. The 
colour development estimates in this study were based on perspective/observational study 
and images were sent to the BIOLOG company for interpretation. This test was done with 
more emphasis in trying to identify the bacteria isolated than profile the physiological 
characteristics of the isolate. The second limitation is that the gel image of the restriction 
digest showed DNA partial digest. Despite this image, the DNA structure of these two 
bacteriophages appeared different, suggesting they are different but for final identification, 
sequence analysis should be done. The third limitation concerns time constraint and 
mechanical failure of the machine as the TEM imaging of the second bacteriophage could 
not be achieved. Also, the novelty of the bacteria and bacteriophages made the designing 
of protocols more complicated, as model protocols had to be slightly adjusted to 
accommodate the characteristics of the isolated bacteria and bacteriophages.  
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Appendix 1. Four-gene phylogeny (sucA, pyrG, rpoB and rplB). 4 rate classes. showing the 
relationship between the ESBL isolates EwS1 and EwB2 (boxed) within the Yersiniaceae. 
Maximum likelihood analysis of 9394 nuelotide sites using model TN93 with 4 rate classes 
generated 3303 patterns, 59.52% of which were monomorphic. Using estimated values of Ts/ts 
ratio = 5.384303, Alpha = 0.871231, maximal likelihood analysis using nearest neighbour 
interchange produced a tree In(L) = -86239.2. P-inv= 0.517210. Bootstrap values above 50% are 
shown above the branches. the ESBL isolates are the ones boxed. 
ESBL Isolates 
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Appendix 2. Four-gene phylogeny (sucA, pyrG, rpoB and rplB) showing the relationship between 
isolates EwS1 and EwB2 within the Enterobacterales. Maximum likelihood using GTR model and 
non-parametric bootstrap analyses produced a tree of L (In) -96031.597630, with alpha = 0.885352, 
P-inv = 0.522864. Bootstrap values are shown above the branches and sequence accession 
numbers are shown in brackets after the OTU names. 
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Appendix 3. Percentage sequence similarity for the genes fusA, sucA, pyrG, rplB and rpoB of the isolates EwS1 and EwB2 with Rahnella species. 
Gene fusA sucA pyrG rplB rpoB 
Organism EwS1 EwB2 EwS1 EwB2 EwS1 EwB2 EwS1 EwB2 EwS1 EwB2 
Rahnella sp. ERMR1:05 (CP019062) 85.01 95.37 88.81 89.03 89.33 89.44 96.12 96.12 94.99 94.99 
Rahnella aquatilis ATCC 33071 (CP003244) 85.55 93.24 88.49 88.71 90.05 90.05 96.24 96.24 94.09 94.09 
Rahnella aquatilis MEM40 (CP036490) 84.79 93.10 88.24 88.46 90.48 90.48 96.24 96.24 93.89 93.89 
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Appendix 4. Iron acquisition, chemotaxis, antibiotic resistance genes of isolates EwS1 and EwB2 
Activity Gene Function Activity Gene Function 
Iron acquisition fbpA Fe(3+) binding periplasmic  heavy metal terZ tellurium resistance 
 fbpB Fe(3+) transport permease  terA  
 fbpC Fe(3+) ion import  terB  
 entF enterobactin synthase  terC  
 entS enterobactin exporter  arsH arsenic resistance 
 entE Enterobactin synthase  tehB  
 entB isochorismatase Antibiotic resistance macA  
 entC isochrismate synthase    
Virulence srfB Virulence protein  mdtA Multidrug transporter. confers resistance against 
novobiocin and deoxycholate. MdtABC requires 
TolC for its function  
  virulence effector protein  acrD aminoglycoside efflux pump 
  virulence factor  mmr methylneomycin resistance 
 yeeJ invasion  bla Beta-lactamase CTX-M-2 
 sprA virulence protein  tcmA tetracenomycin resistance protein 
 sprB mono ADP-ribosyltransferase  bla  
 shlA hemolysin  bla TEM Beta-lactamase TAM 
 hpmB hemolysin transporter  smvA viologen resistance 
 fepA hemoglobin binding Chemotaxis trg methyl accpeting chemotaxis protein III 
 fhaB filamentous hemagglutin  tcp methyl accepting chemotaxis citrate transducer 
 fhaC filamentous hemagglutin 
transporter protein 
Secretion clp VI VI protein 
 hrtE OMP usher protein  icmF type VI secretion protein 
 fimB chaperone protein  datL typw IV/VI secretion system 
 ipfA long polar fimbria protein A  impA type VI secretion associated protein 
 ipfB chaperone  vgr type vi secretion system 
 ipfC outer membrane protein    
 fimG   pqiA paraquate-inducible protein A 
 ydeR fimbrial subunit  pqiB paraquate-inducible protein B 
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Appendix 5. Virulence factors, toxin genes and drug resistance genes of isolates EwS1 and EwB2  
Toxins and virulence factors Drug resistance 
int Intimin emrK erythromycin 
inv Invasin emrB multidrug export protein 
cbtA cytoskeleton-binding toxin mfs spectomycin/tetracycline 
RTX-1 RTX toxin mdtL chloramphenicol 
antigen LP4 O antigen bcr bicyclomycin 
fliC H antigen: flagella component mdtA  
Haemolysin C haemolysin C stp  
pIIT twitching mobility protein mdaB Adriamycin and etoposide 
ipfA Major fimbriae subunit mdtH  
ipfB Major fimbriae chaperone bmr3  
hlgA Class-S component: AB toxin mrcA penicillin binding protein 
hlgB γ-hemolysin: AB toxin mdtG forfomycin, deoxycholate 
pIIQ Type IV pilus biogenesis sttH streptothricin 
shlB outer membrane protein for shlA 
(haemolysin) export 
yheI ABC transporter 
humT hemin-binding periplasmic protein arcA multidrug efflux pump 
hha toxicity modulator protein arcB  
vgrG1 actin crosslinking toxin macA macrolide export protein 
virS  toho1 beta-lactamase 
cyoE protoheme IX famesyltransferase acrD aminoglycoside/multidrug 
transporter subunit 
tomB Attenuates Hha toxicity and 
regulates biofilm formation 
  
yrfK    
yrfJ    
yrfI    
yrfH Heat shock protein 15  colicin V 
loc 311110 taurine binding protein cml colicin M 
caflA F1 capsule anchoring protein mccF microcin C7 
csgA major curlin subunit  barstar 
CsgB curlin minor subunit ratA ribosome association toxin 
csg C aggregative fimbriae protein srpA srpABC pump 
ShlB/FhaC/HecB hemolysin secretion/activation 
protein 
yeeV  
cdi A1 adhesin/hemagglutinin/hemolysin yeeU  
cdi A2 adhesin/hemagglutinin/hemolysin   
CsgG Curli production 
assembly/transport component 
  
CsgF Curli production 
assembly/transport component 
  
CsgE curli assembly protein   
CtsH1 hemolysin coregulated protein 1   
ivy lysozyme inhibitor   
ykfI Toxin YKFI   
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Appendix 6. Maximum likelihood phylogenetic tree showing the relationship of the invasin gene 
sequences (Inv) from isolate EwS1 (Boxed) with those from other members of the Enterobacterales 
and Yersiniaceae.  The maximum likelihood model used to construct the tree was GTR+I+G with 
an estimated P-INV value of 0.057042, and this generated a tree of -In L = 11923.56370 from 687 
distinct data patterns. 
ESBL Isolate 
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Appendix 7. Parsimony consensus tree of invasin sequences from ESBL isolates EwS1 and EwB2 
(Boxed). Tree lenth – 3916, CI = 0.539, RI = 0.562, RC = 0.303, HI = 0.461 
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Heuristic search of a dataset containing 30 OTU generated one tree of length 3756, and 2 tree 
islands. CI = 0.562. RI = 0.601, RC = 0.338, HI = 0.438.  
Maximum Likelihood 
Model: GTR + I + G 
Gamma: 4 categories 
Distinct number of patterns: 1028 
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Appendix 8. Properties of some members in the Siphoviridae family.  
Genus Head T Tail fibres Genome Host Example 
Amigovirus approx. 50nm  approx. 200 nm No 59 kbp Arthrobacter Amigo 
Anatolevirus 50 nm diam  160 – 190 nm  35 kbp Propionibacteriu
m 
Anatole 
Arquatrovirinae/Camvirus 60 nm diam  230 nm  49 kbp Streptomyces Amelia 
Arquatrovirinae/Likavirus     49.5 kbp Streptomyces Aaronocolus 
Attisvirus     47.8 kbp Gordonia Attis 
Triavirus 100 x 45 nm  370 nm Yes 43 kpb Staphylococcus Phage 3a 
Biseptimavirus 60 nm diam  250 nm No 41 kpb Staphylococcus Phage 77 
Andromedavirus 55 nm diam  115 x 21 nm No 49 kbp Bacillus Andromeda 
Barnyardvirus 60 nm diam  360 nm terminal 69-71 kbp Mycobacterium Barnyard 
Bignuzvirus 80 nm  350 nm No 69-71 kbp Mycobacterium bignuz 
Bronvirus 80 nm  350 nm No 69-71 kbp Mycobacterium bron 
Ceduovirus 56 x 41 nm T=4 86 – 111 nm Short 22 kbp Lactococcus Phage c2 
Cequinquevirus 60 nm diam  120 nm, large base No 31 kbp Lactobacillus Phage c5 
Charlievirus 65 x 50 nm  150 nm No 43 kbp Mycobacterium charlie 
Cheoctovirus 60 nm  120 nm, large base No 56-58kbp Mycobacterium Che8 
Chenonavirus 150 x 50 nm  250 nm No 47-57 kbp Mycobacterium Che9c 
Chivirus 66 nm diam  220-230 nm x 13 nm 200-220 nm 59 kbp Salmonella Chi 
Kostyavirus 60 nm diam  170 nm No 74-76 kbp Mycobacterium CJW1 
Corndogvirus 173 x 43 nm  258 nm No 70 kbp Mycobacterium corndog 
Casadabanvirus 40 nm diam  190 nm Yes? 37 kbp Pseudomonas D3112 
Detrevirus 55 nm diam  113 x 7 nm 6 with knob 98 kbp Pseudomonas D3 
Liefievirus 70 nm diam  220 nm No 42 kbp Mycobacterium Phage halo 
Dhillonvirus 60 nm diam  140 nm  40-45 kbp Escherichia HK578 
Cecivirus 55 nm diam  150 nm transverse tail discs 53 kbp Bacillus IEBH 
Jerseyvirus 62-64 nm diam  116-120 nm spikes on Base 20 nm 40-43 kbp Salmonella jersey 
Fromanvirus 60 nm diam  135 x 8 nm Short fibre 52 kbp Mycobacterium L5 
Lambdavirus 60 nm diam T=7 120-130 nm Yes 48 kbp Escherichia Lambda 
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Genus Head  T Tail Fibres Genome Hosts Example 
Ravinvirus 60 nm diam  140 x 8 nm Yes, short 46 kbp Enterobacter N15 
Omegavirus 100 nm diam  230 nm No 106-112 kbp Mycobacterium omega 
Oshimavirus 100 nm diam T=7 1000 nm No 84 kbp Thermus P2345 
PBI-like 60 nm  360 nm single 64 kbp Mycobacterium PBI1 
Pegunavirus 60 nm diam  360 nm single 67-71 kbp Mycobacterium Pg1 
Lomovskayavirus 53 nm  100 5 nm; 15nm base 4 tails 43 kbp Streptomyces phiC31 
Phicbkvirus 205x60 nm  350 nm No 205-13 kbp TR Caulobacter phicbk 
Stanholtvirus 63 nm diam  203 x 8 nm No 48-53 kbp Burkholderia phie125 
Phietavirus 50 nm diam  175 nm No 43 kbp Staphylococcus phieta 
Phifelvirus     36-40 kbp Enterobacter Phi FL1 
Coetzeevirus 59 nm diam  182 x 11 nm Spikes 37 kbp Lactobacillus Phi JL1 
Psimunavirus 55 nm diam  210x10 nm term knob Spike/fib 30 kbp Methanobacteriu
m 
Phi M1 
Reyvirus 75 nm diam  300 nm No 83 kbp Mycobacterium rey 
Saphexavirus 120x45 nm  160 nm No 54-59 kbp Enterococcus VD13 
Brussowvirus 100 nm  400 nm No 40 kbp Streptococcus Sfi 11 
Moineauvirus 60 nm diam  260x8 nm  35 kbp Streptococcus DT1 
Skunavirus 45 nm diam  120 nm No 28 kbp Lactococcus SK1 
Spbetavirus 81 nm diam  335x10 nm 6 tail 134 kbp Bacillus SPbeta 
Tequintavirus 90 nm diam T=13 160x11nm – 50 nm fiber 3 tail (120n 121 kbp Enterobacteria T5 
Timquatrovirus 60 nm diam  600 nm No 52-62 kbp Mycobacterium TM4 
Lwoffvirus 58 nm diam  145 x 11 nm single 37 kbp Bacillus TP21-L 
Tunavirus 60 nm diam  151 x 8 nm  4 tail 50 kbp Enterobacteria T1 
Wbetavirus 50 nm diam  200 nm Cent fibre 36-40 kbp Bacillus Wbeta 
Xipdecavirus 53 nm diam  173 nm 2-6 tail 44 kbp Xanthomonas Xp10 
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Appendix 10. Completed UPR16 form 
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